S-VENTURES
PLC
("S-Ventures plc" or "the
Company")
Group Strategic
Report, Report of the Directors and
Consolidated
Financial Statements
for the 15
Months Ended 31 December 2023
S-Ventures
plc (AQSE: SVEN) (OTCQB: SVTPF), the Company investing in and
growing exciting brands across the natural, wellness and food-tech
categories, is pleased to announce the audited results of the
Company for the 15-month period ended 31 December 2023. These
accounts have been delayed for the reasons outlined in the
Chairman's statement. The Company will soon be in a position to
publish its interim report for the six-month period ended 30 June
2024 at which time it will provide an update on its current plans.
Following publication of the interim results, the Company
will apply for the lifting of suspension in trading in the
Company's shares.
For further
information contact:
The Company
+44 (0) 203 475 0230
Scott
Livingston
Stephen
Argent
AQSE
Corporate Advisor and Broker
+44 (0) 20
3005 5000
VSA Capital
Limited
Andrew
Raca
Dylan
Sadie
|
PAGE
|
Company
Information
|
3
|
Chairman's
Statement
|
4
|
Group
Strategic Report
|
5
|
Section 172
Statement
|
10
|
Report of
the Directors
|
11
|
Report of
the Independent Auditors
|
17
|
Consolidated Statement of Profit or Loss and
Other Comprehensive Income
|
24
|
Consolidated Statement of Financial Position
|
25
|
Company
Statement of Financial Position
|
27
|
Consolidated Statement of Changes in Equity
|
28
|
Company
Statement of Changes in Equity
|
30
|
Consolidated Statement of Cash Flows
|
32
|
Company
Statement of Cash Flows
|
33
|
Notes to
the Consolidated Financial Statements
|
34
|
DIRECTORS:
S Argent
(appointed 29 August 2023)
B
Choudhrie
R D
Hewitt
S P
Livingston
D M
Mitchell (resigned 15 January 2024)
N A
D'Onofrio (resigned 26 July 2023)
A J B
Phillips
SECRETARY:
R D
Hewitt
FINANCIAL
ADVISOR:
VSA Capital
Limited, Park House, 16-18 Finsbury Circus, London, EC2M
7EB
AUDITORS:
RPG Crouch
Chapman LLP, 40 Gracechurch Street, London EC3V 0BT
LAWYERS:
Hill
Dickinson LLP, The Broadgate Tower, 20 Primrose Street, London,
EC2A 2EW
REGISTRARS:
Neville
Registrars, Neville House, Steelpark Road, Halesowen, B62
8HD
REGISTERED
OFFICE:
Suite 8,
3rd Floor, 121 Sloane Street, London, SW1X 9BW
REGISTERED
NUMBER:
12723377
(England and Wales)
The Board
is pleased to present the Company's audited results for the 15
months ended 31 December 2023. As previously announced, the
year-end has been extended to be coterminous with that of our
largest subsidiary - Juvela Limited - which we acquired in December
2022.
The Board
regrets the late submission of these accounts which has been
occasioned by a difficult trading period and a change in auditors.
We anticipate releasing our Interim Accounts to June 2024
shortly to bring us back in line with reporting
requirements.
The results
reflect the headwinds we have encountered with the closure of Lizza
GmbH (March 2023) and more recently the closure of Ohso Chocolate
(September 2023). Against these disappointments, we are very
pleased with the success of Juvela whose first-year results were in
line with expectations. Juvela supplies gluten free products
largely to the prescription market and has recently expanded its
product range.
The
turnaround at Pulsin has been slower than anticipated and the
period to December 2023 reflected considerable costs which we have
now eliminated from the business. This turnaround has
continued through 2024 and we anticipate that Pulsin will return to
profitability in early 2025.
Growth has
continued at Market Rocket which continues to tap into new and
developing marketing platforms.
Since the
2023 year-end, we have refined or expanded the ranges of products
at both Pulsin and Juvela which gives the Board renewed confidence
for future trading periods.
On 22 March
2024, we announced a £2 million debt fund-raising to bridge to a
potential purchase of assets and novation of liabilities by
Riverfort Global Opportunities plc ("RGO"). The Board
continues to progress this important potential transaction with the
final phase of preparation now underway with the issuance of these
audited accounts. RGO have undertaken significant due
diligence and the Board anticipates being able to make a further
statement shortly after the publication of these
accounts.
The Board
continues to work closely with group companies, offering
operational, expertise and financial support, enabling them to grow
faster than otherwise might have been the case if standing
alone.
I would
like to express our gratitude to our employees, board members and
shareholders for their efforts and continued support and for making
our progress to date possible. I am also announcing my
intention to stand down as a director as the forthcoming
AGM.
--------------------------------
R D
Hewitt
Non
Executive Chairman
CEO's
REPORT
We are
pleased to present our audited results for the period ended 31
December 2023. These have taken longer than expected and, similar
to the prior year, have been complex due to a number of factors.
These include the liquidation of our foreign German subsidiary,
alongside impairment reviews across the acquisitions we have made
in the last 2 years.
It is safe
to say that the environment remained very tough, with a combination
of issues such as wage and ingredients inflation, as well as
general cost increases and headwinds that have contributed to a
difficult period. We can now confirm that most areas have
shown recent improvement and the businesses are slowly returning to
more stable trading with growth and opportunity coming back into
the plan. We have been focused on driving value from internal
efficiencies and the supply chain and managing financial risk as
opposed to aggressive growth plans in the recent market
environment.
I am
pleased to report a number of positives:
·
170% annualised revenue growth
to £20m
·
Launching of new products
across the main brands Juvela and Pulsin
·
Juvela remains on plan and
profitable with an EBITDA in excess of £2m
·
Market Rocket grew revenues
210% and launched its Marketverse platform
·
Pulsin's cost-cutting exercise
has concluded allowing for a return to
profitability in early 2025
·
Key decisions taken to
discontinue certain smaller, capital-intensive businesses (OHSO,
Livia's)
The first 3
years of the group's activity has seen significant growth in
revenues through acquisition in what has been a difficult trading
period:
Split of the £20m revenue for the
current period
Juvela
|
£8.0m
|
Pulsin
|
£7.5m
|
Market
Rocket
|
£3.7m
|
Purely
|
£0.4m
|
Discontinued operations
|
£0.8m
|
2021
|
£1.6m
|
2022
|
£9.3m
|
2023
(15 months)
|
£20.4m
*
|
* includes
discontinued operations revenue
In order to
meet our obligations to Hero for the final deferred payment for the
acquisition of Juvela, to support central costs of a listed
business and, to a lesser extent, to support trading, we sought to
raise funding of £2.5 million in the last quarter of 2023.
With equity markets not offering liquidity or value, we
raised a total of £3 million of debt facilities in the following
months, including £1 million of facilities from a Middle Eastern
family office and £2 million of facilities from RGO alongside the
announcement of RGO's potential acquisition of our subsidiaries and
novation of liabilities. Given difficult market conditions, this
was a testament to the underlying operating prospects of our
businesses.
The Board
continues to progress this important potential transaction (the
"Transaction") in close collaboration with the Board of RGO.
The Transaction that is proposed is intended to raise enough
capital to settle all of the parent company's loans, leaving only
the subsidiary loan at Juvela in place and approximately halving
the financial debt carried by our group of businesses. The
subsidiary loan at Juvela, which was used for its acquisition, has
been reduced significantly through operating cashflow and as at
December 2024 the amount owed to Shawbrook is now approximately
£4m.
We continue
to be very focused on the progress of our brands and, following the
release of these audited accounts, we will update the market on the
new products we are launching alongside recent and up-to-date
progress for all the divisions.
--------------------------------
S P
Livingston
Chief
Executive Officer
FINANCIAL
REVIEW
Introduction
During the
fifteen months ended 31 December 2023, the focus has continued to
be on restoring the existing businesses to profitability, whilst
integrating Juvela Limited into the group. Juvela and Market
Rocket are both delivering positive EBITDA on a monthly basis and
Pulsin is expected to achieve that by early 2025.
The group
has grown its gross sales to £22.5m before trade discounts of £2m
resulting in net sales of £20.5m. but sustained losses of £6.6m
after costs of acquisition and impairments.
The loss
includes some £0.5m of one-off costs comprising costs associated
with acquisitions (£0.4m) and impairment of goodwill
(£0.1m).
Trading
margins improved across the group from 33% to 45%.
The
directors do not propose to declare a dividend. The resultant loss
represents a 5.04p (2022- 2.92p) loss per share in issue at the end
of the financial period.
Comments on performance of
our owned businesses:
PLANT BASED
NUTRITION
Pulsin
Pulsin
(www.pulsin.co.uk) is a well-established and highly respected
plant-based nutrition company, excelling in plant-based nutrition
technology, manufacturing and sales, with a focus on healthy
protein bars, nutritional snacks and Keto bars. Pulsin formulates
and produces high quality plant-based products under its own brands
as well as for third parties, from its specialised facilities in
Gloucester.
Pulsin's
award-winning range of tasty snack bars, protein powders, keto
products and shakes are packed full of feelgood nutritional
goodness and balanced with the right amount of super ingredients.
The Pulsin range is gluten free and suitable for vegetarians, with
the majority being plant-based too. Pulsin never uses artificial
ingredients, preservatives or palm oil. The products are available
at most large retailers such as Sainsbury's, Tesco, Boots, Asda,
Holland & Barrett and Ocado.
Pulsin had
gross sales of approximately £7.5m in the fifteen months to 31
December 2023 (2022 - £7.5m). The lack of growth is a little
disappointing, but the focus in bringing the business back to
profitability has delayed the introduction of new products which
were launched in 2024.
The
business implemented a major shift in strategy during this period,
moving focus away from lower margin contract manufacturing work
towards driving growth and profitability of Pulsin-branded
products. This involved a number of key initiatives including the
termination of a loss-making contract with the largest private
label customer, worth over £2m per annum in revenue.
The
business was able to use this as an opportunity to fast track key
Pulsin new projects, including the launch of 3 new premium
flavoured protein powder products and the start of other projects
to build on the success of the best-selling range of keto bars and
powders. There was an increase in investment with key customer
accounts, particularly Amazon, as part of a plan to drive more
branded sales through online channels, which is considered key to
the success of challenger food brands within the wellness
sector.
Sales grew
rapidly during this time but profitability dropped significantly as
a result of increased marketing investment and margin support.
Towards the end of this period the business undertook a major
rationalisation of its operations. The reduction in contract
manufacturing work enabled the business to exit the lease of a
costly secondary storage and distribution site in Brockworth
resulting in major savings for following year. Accordingly, the
business has been able to start the next financial year with lower
levels of overhead and marketing investment with renewed focus on
building branded revenue and profitability as the key priority.
The process of cost reduction and review of the supply chain
during 2024 was a continuing feature as the business is moved to a
more secure footing.
We Love
Purely
We Love
Purely is a UK-based plantain crisp brand with an emphasis on
sustainability and natural ingredients. Available at many leading
stores including Holland & Barrett, Ocado, Selfridges, Harvey
Nichols, Harrods and Planet Organic.
The year
has been one of resilience and strategic progress for We Love
Purely. Despite facing several operational challenges,
including production delays, extended customer payment cycles, and
global shipping disruptions, the company has managed to mitigate
the impact on its turnover. While EBITDA reflects these
operational pressures, the company has still achieved significant
milestones that position it for future growth.
We Love
Purely achieved a turnover of £0.4m for the 15 months to 31
December 2023, with an EBITDA loss of £247k. This compares to a
turnover of £0.4m for the 12 months to 31 December 2022, with an
EBITDA loss of £217k. Stabilising turnover under challenging
circumstances marks a notable achievement. Key to this has been the
strategic investment in launching products with major supermarket
chains such as Holland & Barrett in the UK and Benelux.
Additionally, the company secured new partnerships within the
foodservice sector, including collaborations in the private jet
catering market. The business's European footprint has also
expanded significantly, with a stronger presence in Switzerland,
the Netherlands, and Portugal.
The
operational challenges faced were primarily linked to supply chain
issues and the company has taken decisive steps to mitigate these
risks in the future. Plans are underway to diversify the supplier
base, which will reduce dependency on a single source and improve
supply chain resilience. The business is also preparing to launch a
new product line in a category outside snacking. This strategic
move will not only differentiate the company's offering but also
balance its risk profile.
The company
has also made infrastructure improvements by establishing new
storage and distribution arrangements and initiating discussions
with a potential supply chain partner. These measures aim to
enhance cost efficiency and operational effectiveness, setting the
stage for a more profitable business model in the near term.
Looking forward to the upcoming year, We Love Purely remains
committed to driving growth through innovation, operational
excellence, and strategic expansion.
Ohso
Chocolate
Following
continuing technical difficulties with the manufacturing process of
the products and a consequential drop in sales revenues, it was
decided that Ohso should be absorbed into Pulsin Limited. The
turnover for this period of £0.09m was the result of winding down
the company's operations and selling off any remaining stock.
The accounts include an impairment of the remaining £0.03m of
the original investment.
BAKERY
DIVISION
Following
the closure of Lizza in March 2023 any remaining net assets have
been fully impaired and all intercompany debt written off.
This leaves Juvela as the sole operating company within the
bakery division, a business acquired in mid-December
2022.
Juvela
Juvela is a
specialist bakery company producing a range of gluten-free flours
and bakery products, mainly sold through the NHS prescription
channel, where the company has a greater than 50% share of the
market.
The
business continues to perform in line with expectations, generating
a turnover of £8m for the 12 months to 31 December 2023, with an
EBITDA of £2.4m
Following
the purchase of Juvela in December 2022, 2023 has been very much a
stabilising year for the company and its markets, after leaving the
Hero Group, its previous owner. Juvela was able to migrate
away from some Hero-group suppliers for its bakery and consumer
products and bring this supply solely into the UK. This was
reflected in the company's stable turnover and EBITDA numbers for
2023.
2023 was
the year that Juvela strengthened its team to get ready to attack
the UK retail market and diversify the portfolio further from its
standard prescription products. It developed a new
NPD/Retail-focused team, recruiting an NPD manager and Sales
Manager. It also started a process to build a new
allergen-free bakery adjacent to its gluten-free bakery and this
was ready for the successful retail launches in September
2024.
TECHNICAL
SERVICES
Market
Rocket Limited continues to grow and develop its range of services,
especially its Marketverse platform, where it manages the online
sales strategies for other companies on Amazon and other online
platforms.
The company
has experienced significant growth during the 15-month period to 31
December 2023, with turnover increasing to £3.7m. This was driven
by strategic initiatives and operational expansion. While the
EBITDA % for the current period is down, compared to the previous
comparable periods, this reflects our ongoing investment in scaling
the business to support future growth.
Key drivers
of this growth include the successful onboarding of both blue chip
and market-disrupting new clients through our dedicated sales team,
which leverages AI technology to prequalify leads and streamline
the path to initial meetings. Additionally, the expansion of our
"Marketverse" direct selling offering has opened new revenue
streams, further solidifying our position as a leader in D2C
support.
Notably,
the last 15 months have marked our transition into a full-service
D2C agency, offering off-Amazon services to complement our core
Amazon expertise. We have secured key partnerships and
accreditations with TikTok, Meta, Google, and Semrush, enhancing
our capabilities alongside our established credentials as a member
of the Amazon Service Provider Network and Verified Advertising
Partner. These developments position us well for continued growth
and innovation in the years ahead.
Cash flow and cash
position
Up until
recently, funding for the group activities has come from
shareholder monies. The directors recognised the need for
additional funding and organised a bridging loan of £1m in November
2023, whilst the negotiations to raise further capital of £2m,
referred to in the CEO's report, were being organised.
Meanwhile, the Board continues to progress RGO's potential
acquisition of our subsidiaries and novation of liabilities in
close collaboration with the Board of RGO. This is intended
to raise enough capital to settle all of the parent companies
loans, leaving only the subsidiary loan at Juvela in place and
approximately halving the financial debt carried by our group of
businesses.
INVESTMENTS
Coldpress Foods
Limited
Coldpress
continues to trade and there has been no impairment in the value of
this investment.
Plant Punk
Despite an
optimistic start, we were disappointed that the business failed to
develop any products. Accordingly, the value of our 50% joint
venture in Plant Punk has been fully impaired in these
accounts.
CURRENT
TRADING
Since the
balance sheet date, the growth in all companies, together with the
cost-cutting, efficiencies and rationalisations being implemented
are all beginning to bear fruit.
PRINCIPAL RISKS AND
UNCERTAINTIES
Our key
risks can be summarised as follows:
Risk
|
Impact
|
Mitigation
|
Foreign
exchange
|
Currency
volatility impacts our cost of goods in We Love Purely as the
product is sourced in US dollars. There is also some impact
on European sales in Euros for Pulsin, We Love Purely and
Juvela.
|
The Group
does not hedge its foreign exchange exposures. We keep
exchange risk under review and as sales grow for the Group we will
be looking to lock in exchange rates.
|
Key
Suppliers
|
Risk that
failure of supply by a major supplier would impact on our ability
to service our customers.
|
This is not
an issue for the group save for We Love Purely which is reliant on
mainly one supplier. The position is regularly reviewed.
|
War in
Ukraine
|
Initially
the outbreak of war caused a temporary delay in supplies and also
increased the prices. This has now receded.
|
We continue
to be aware and look for alternative sources of
materials.
|
Credit and
Liquidity risks
|
Lack of
working capital would impact the group's ability to acquire goods
and services.
|
Where
issues arise, we work with suppliers to ensure continued supply, in
some cases rescheduling the payment terms. The group is
working on a capital raising project that should leave it with
access to additional funds to alleviate this issue
|
Insurance /
Regulatory risk
|
Loss
occasioned by product issues and normal commercial risks
|
All our
businesses carry appropriate insurance cover for product liability
and other risks.
|
SECTION 172
STATEMENT
The Board
of Directors, in line with their duties under section 172 of the
Companies Act 2016, act in a way they consider, in good faith,
would be most likely to promote the success of the Company for the
benefit of its members as a whole, and in doing so have regard to a
range of maters when making decisions for the long term. Key
decisions and maters that are of strategic importance to the
Company are appropriately informed by s172 factors.
Section 172
of the Companies Act 2006 requires Directors to take into
consideration the interests of stakeholders and other matters in
their decision making. The Directors continue to have regard to the
interests of the Company's employees and other stakeholders, the
impact of its activities on the community, the environment and the
Company's reputation for good business conduct, when making
decisions. In this context, acting in good faith and fairly, the
Directors consider what is most likely to promote the success of
the Company for its members in the long term. We explain in this
annual report, and below, how the Board engages with
stakeholders.
The Board
regularly reviews the Company's principal stakeholders and how it
engages with them. This is achieved through information provided by
management and also by direct engagement with stakeholders
themselves.
The table
below sets out some examples of how the directors have exercised
this duty:
Stakeholder
|
How we
engage
|
Our
Shareholders
The Board
and Executive Management Team maintains strong relationships with
investors and supports open channels of communication.
|
The Company
proactively engages in dialogue with shareholders. Since the IPO in
September 2021, the CEO has participated in number of investor
presentations and at various other investment led
events.
Our next
AGM will be held during the week commencing 3rd February
2025. This will provide an opportunity for shareholders to
meet the directors and discuss the year's results.
Website and
shareholder communications
Further
details on the Group, our business and key financial dates can be
found on our corporate website:
htps://www.s-venturesplc.com/
|
Our People
Our employees are at the core of all that we do.
|
At
S-Ventures, we believe that our strength comes from our staff and
success comes from shared goals and values. We are proud to
celebrate the diversity of our employees and work hard to empower
our workforce and to create a positive and inclusive culture within
which our teams can grow. The sustainable success of the business
is dependent upon the development of and investment in our teams of
highly talented and dedicated employees. Our teams are kept
fully informed of the business' performance, operational and
strategic initiatives through newsletters and quarterly townhalls.
We continually strive to maintain open communication and encourage
collaboration from all our employees.
|
Our
Customers and Brand partners Communication with our customers and
brand partners is fundamental to understanding how we can continue
to add value through the products and in the services we
provide.
|
The trust
of our customers and partners is fundamental to our success. We are
committed to building innovative customer-led technology solutions
and products. We maintain a strong relationship with our partners
through our dedicated accounts management team. Through
regular meetings and conversations, we regularly review their
feedback which enables us to improve the services and solutions we
provide.
|
Our
Suppliers The relationship we have with our suppliers is key to
ensuring that the quality of the products we deliver to our
customers are maintained at a high standard and the delivery is
managed for the smooth-running of our business and its
operations
|
We rely on
suppliers and logistics partners across a number of geographical
locations. Throughout the year we continue to work closely with our
key suppliers and logistics partners to manage those relationships
with clear communications to ensure the high quality of our
products and services are maintained.
|
The
directors present their report with the financial statements of the
company and the group for the 15 months ended 31 December
2023.
DIVIDENDS
No
dividends will be distributed for the period ended 31 December
2023.
FUTURE
DEVELOPMENTS
Details of
the Group's future developments are contained in the Strategic
report set out above.
EVENTS SINCE THE END OF THE
PERIOD
Information
relating to events since the end of the period is given in Note 37
to the financial statements.
DIRECTORS
The
directors who have held office during the period to the date of
this report are as follows:
S Argent
(appointed 29 August 2023)
B
Choudhrie
R D
Hewitt
S P
Livingston
D M
Mitchell (resigned 15 January 2024)
N A
D'Onofrio (resigned 26 July 2023)
A J B
Phillips
REMUNERATION COMMITTEE
REPORT
The
Remuneration Committee has responsibility for determining, within
the agreed terms of reference, the Group's policy on the
remuneration packages of the Company's Chairman, and the executive
directors and such other members of the senior management as it is
designated to consider. The Remuneration Committee also has
responsibility for determining (within the terms of the Group's
policy and in consultation with the Chairman of the board and/or
the Chief Executive Officer) the total individual remuneration
package for each executive director and other senior managers
(including bonuses, incentive payments and share options or other
share awards). The remuneration of non-executive directors is a
matter for the independent board. No director or manager will be
allowed to partake in any discussions as to their own remuneration.
In exercising this role, the directors shall have regard to the
recommendations put forward in the relevant QCA
Guidelines.
In the 15
months to 31 December 2023, the Remuneration Committee consisted of
the Non-Executive Chairman and two non-executive directors: David
Mitchell, Alex Phillips and Bhanu Choudhrie. The Remuneration
Committee is convened not less than twice a year and otherwise as
required. The Committee met twice during the period ended 31
December 2023.
Directors' Remuneration
Policy
The
Committee takes into account both Group and individual performance,
market value and sector conditions in determining director and
senior employee remuneration. The Committee has maintained a policy
of paying salaries comparable with peer companies in the sector in
order to attract and retain key personnel.
For the
first part of the period under review, these costs were kept very
low reflecting the Group strategy of building for the future. In
future periods, salary costs are likely to rise.
Directors
remuneration
15 months ended 31 December
2023
Executive
directors
|
Salary
|
Pension
|
Benefits
|
Bonus
|
Total
|
Scott
Livingston
|
150,000
|
7,500
|
22,500
|
-
|
180,000
|
Robert
Hewitt
|
75,000
|
-
|
-
|
-
|
75,000
|
Stephen
Argent
|
40,000
|
-
|
-
|
-
|
40,000
|
Prior period year ended 30
September 2022:
Executive
directors
|
Salary
|
Pension
|
Benefits
|
Bonus
|
Total
|
Scott
Livingston
|
124,333
|
-
|
1,894
|
-
|
126,226
|
Robert
Hewitt
|
60,000
|
-
|
-
|
-
|
60,000
|
Fees
payable
Non- executive
directors
|
15 months
ended
31 December
2023
|
Year ended
30 September
2022
|
David
Mitchell
|
50,168
|
30,000
|
Alex
Phillips
|
20,758
|
12,000
|
Nick
D'Onofrio
|
-
|
12,000
|
Bhanu
Choudhrie
|
23,000
|
12,000
|
Service Contracts and
non-executive directors' Letters of Appointment
The
executive directors have rolling contracts that are terminable on
12 months' notice. These contracts are not fixed term and will be
reviewed annually. The chairman has an agreement entitling him to
£30,000 pa and the other non-executive directors have agreements
entitling them to fees of £12,000 pa. Fees of £1,000 per month were
accrued for services provided in the current period.
During the
15 months ended 31 December 2023, there were 13 minuted Board
meetings plus a further 2 informal meetings.
Directors' interests as at 31
December 2023
Director
|
Ordinary shares directly
held
|
% of Issued Share
Capital
|
Warrants at
25p
|
Options
|
Scott
Livingston
|
46,749,108
|
35.4%
|
-
|
-
|
Robert
Hewitt
|
2,332,003
|
1.8%
|
-
|
-
|
David
Mitchell
|
1,926,859
|
1.5%
|
-
|
-
|
Alex
Phillips
|
2,746,000
|
2.1%
|
-
|
-
|
Nick
D'Onofrio
|
2,750,000
|
2.1%
|
-
|
-
|
Bhanu
Choudhrie
|
-
|
-
|
-
|
-
|
Number of
shares in issue at 31 December 2023
|
132,215,587
|
Number in
issue at date of this report
|
132,215,587
|
Share Options and
Warrants
There is
one set of warrants exercisable at 4p and an option exercisable at
15p.
|
As at 31 December
2023
|
As at the date of this
report
|
Shares in
issue
|
132,215,687
|
132,215,587
|
Warrants
for shares
|
737,800
|
737,800
|
Share
Options
|
66,666
|
66,666
|
Diluted
number of shares
|
133,020,053
|
133,020,053
|
Percentage
of Warrants and Options in expanded equity
|
0.6%
|
0.6%
|
Shareholder Approval of
Directors' Remuneration Report
Shareholders are asked to approve this directors' Remuneration
Report for the period ended 31 December 2023 at the forthcoming
Annual General Meeting. This resolution is advisory in
nature.
STATEMENT OF CORPORATE
GOVERNANCE ARRANGEMENTS
Introduction
We are
pleased to set out below the Corporate Governance Report for the 15
months ended 31 December 2023. As an AQSE quoted company, we
recognise the importance of sound corporate governance in
supporting and delivering the strategy of the Company and its
subsidiaries (together the "Group"). This involves managing the
Group in an efficient manner for the benefit of its shareholders
and other stakeholders whilst maintaining a corporate culture which
is consistent with our values.
The Company
adopted the QCA Corporate Governance Code ("QCA Code") on its
initial listing. The Company's Corporate Governance Statement is
available to view on the Company's website at
www.s-venturesplc.com
The board
of directors is responsible for the long-term success of the
Company and, as such, devises the Group strategy and ensures that
it is implemented. The board is determined that the Company
protects and respects the interests of all stakeholders and in
particular, is very focused upon creating the right environment for
its employees. We want a happy workplace and we want our employees
to be fully and properly rewarded and to feel that they are an
integral part of the S-Ventures family. A reward structure is in
place which, inter alia, allows for the grant of share options,
enabling members of staff to participate in the growth of the
Company, as appropriate.
We want our
suppliers, who are an essential part of the Company, to also feel
part of the S-Ventures family and we work closely with them to
ensure that this is the case. Above all, the Company wishes to
ensure that shareholders obtain a good return on their investment
and that the Company is managed for the long-term benefit of all
shareholders and other stakeholders. Appropriate Corporate
Governance procedures will ensure that that is the case and reduce
the risk of failure.
The Development of the Code
for S-Ventures
The QCA
sets out 10 principles which the Board is working on to expand into
an effective document to cover all areas of the Group's business.
During 2023 the board reviewed whether the Quoted Companies
Alliance (QCA) code remains appropriate to continue following, the
substitute that was considered was the UK Corporate Governance Code
published by the Financial Reporting Council (FRC). Due to the size
of the Company and the prescriptive nature of the UK Corporate
Governance Code a decision was made to continue abiding by the QCA
code.
The Group
has a clear mandate to optimise the allocation of resources to
support its development and growth plans seeking to maintain a
balance between its resources and maintaining robust corporate
governance practices. As the Group evolves, the Board is committed
to enhancing the Company's policies and practices appropriate for
the size and maturity of its business and organisation.
Set out
below are the Group's corporate governance practices for the 15
months ended 31 December 2023.
1.
Business
strategy
The
business model involves seeking out strong brands or products with
a clear market message within the wellness sector. To date this has
meant focusing of healthy snacks market. Conscious of present
trends in plant-based foods, the products should be both better for
the consumer and also have a better carbon and / or health benefit
than competing products. By being in the forefront of these trends,
the Board considers that shareholder value will be
promoted.
2.
Shareholder
needs
Other than
promoting growth and thus shareholder value, we aim to develop ways
of communicating effectively with our shareholders to ensure we are
developing appropriately. As the group grows this will become more
important; for the time being, this is achieved by data on our
website, press notices and the full presentation of our annual
accounts.
3.
Wider responsibilities, such as
social responsibility
With both
our existing and new products, our teams are focused on bringing
products to market using responsibly sources raw materials and
packaging materials.
4.
Risk Management
We
consider risk management at two levels. Firstly, we ensure that all
our products are made to appropriate and up to date food hygiene
standards. Secondly, we have implemented reporting and management
systems appropriate to a Group of our size at both the operating
company level and main board level. We have ensured that the group
carries appropriate insurance covers.
Secondly,
the main Board has set up committees which include non-executive
directors for investment decisions, remuneration and audit. Whilst
the Investment Committee sift possible targets, all offers are
approved by the full main Board.
5.
The Board
The Board
members are listed on page 1. The board meets regularly online and
in person. During the 15 months ended 31 December 2023, there have
been 13 minuted Board meetings plus a further 2 informal minuted
meetings.
New board
appointments would be considered by the CEO and Chairman before
consulting with the whole Board.
The full formal Board meetings have a formal structure covering
recent developments, present finance and funding issues,
acquisition policies and progress together with any shareholder or
exchange issues reported by our advisors or which need to be passed
on to them.
6. Board
skills
The
Directors have a wide range of skills including experience of the
retail and online sales structures and the non-executive directors
are able to bring to bear their knowledge gained in the wider
M&A marketplace. As the Company is in the retail and online
sector these are considered to the most appropriate
skills.
Below the
board, we have skilled managers in the Manufacturing units and also
experts in online selling to manage the digital presence of the
constituent businesses of the group.
The Board
regularly reviews the skills needed to run and develop the group's
activities.
7.
Evaluate board
performance
Based on
clear and relevant objectives, seeking continuous improvement. Now
S-Ventures has been operating since July 2020, the Board plans to
put in place a more rigorous evaluation for the subsequent
financial year. The proposed evaluation is a formal internal
evaluation consisting of the following:
•
Attendance of directors to
Board meetings;
•
Questionnaires completed by
each director to determine the boards effectiveness; and
•
One-on-one discussions with
the Chairman
The
questionnaire mentioned above is anonymised to promote honesty in
answering the questions that are being posed to the directors.
Oversight and implementation of actions identified from the
questionnaire are to be completed by the Company Secretary. Should
external insight be required to facilitate this evaluation then
this will take place however, in the current financial year this
was not deemed necessary.
In
addition to this, succession planning also forms part of our
evaluation of the Board to ensure all directors are aware of what
would occur should a prescribed scenario arise.
8.
Promote a corporate
culture
Based on
ethical values and behaviours.
Since
S-Ventures was founded the Board has been insistent on ensuring
that ethical values and good behaviour within the Company is
promoted and maintained throughout the organisation and that they
guide the Company's day-to-day operations, as well as business
objectives and strategy.
S-Ventures
ethical values are promoted to employees from inception at the
interview process through to employment regardless of the working
arrangement. S-Ventures ethical values also hold true for
businesses which we acquire or invest in, should customers,
suppliers or partners not adhere to S-Ventures ethical values
business transactions will not cease. S-Ventures has an open-door
policy and a flat organisation structure to ensure all employees
are empowered to speak their opinion in a comfortable and accepting
environment. All employees' contracts whether employed directly by
S-Ventures or by one of our businesses contain further information
on the values and behaviours expected from staff.
9.
Maintain governance
structures
With
processes that are fit for purpose and support good decision-making
by the board
The
S-Ventures Chief Executive Officer, Chief Financial Officer and
senior management are accountable for the day-to-day operations of
the business and for the implementation of the strategic goals
agreed by the Board of directors. The Chairman leads the Board and
is responsible for its governance structures, performance, and
effectiveness. The Chairman is also responsible for ensuring that
the links between the Board and the shareholders, are strong and
efficient.
10.
Communication
Communicate how the company is governed and is performing by
maintaining a dialogue with shareholders and other relevant
stakeholders.
The board
recognises that the AGM is an important opportunity to meet private
shareholders. Each substantial issue is the subject of a separate
resolution at the AGM and all shareholders have the opportunity to
put questions to the board. All board directors will endeavour to
attend AGMs and answer questions put to them which may be relevant
to their responsibilities.
The share
ownership of majority shareholders can be found on the S-Ventures
website using the following link (www.
S-Ventures/Investor-Information) shareholders are communicated
through the Annual Report and Accounts, full-year and half-year
announcements, social media posts that are displayed on the
S-Ventures website and on acquired companies social media, the AGM
and individual/group meetings with existing or potential new
shareholders. A plethora of corporate information on S-Ventures and
on acquired companies can be found on the S-Ventures website using
the above following link.
STATEMENT OF DIRECTORS'
RESPONSIBILITIES
The
directors are responsible for preparing the Group Strategic Report,
the Report of the Directors and the financial statements in
accordance with applicable law and regulations.
Company law
requires the directors to prepare financial statements for each
financial year. Under that law the Directors are required to
prepare the Group and Company Financial Statements in accordance
with UK-adopted international accounting standards and as regards
the Company financial statements, as applied in accordance with the
requirements of the Companies Act 2006.
Under
company law the directors must not approve the financial statements
unless they are satisfied that they give a true and fair view of
the state of affairs of the company and the group and of the profit
or loss of the group and the Company for that period. In preparing
these financial statements, the directors are required
to:
-
select suitable accounting policies
and then apply them consistently;
-
make judgements and accounting
estimates that are reasonable and prudent;
-
state whether the applicable
UK-adopted international accounting standards have been followed
subject to any material departures disclosed and explained in the
financial statements; and
-
Prepare the financial statements on
the going concern basis unless it is inappropriate to presume that
the company will continue in business.
The
directors are responsible for keeping adequate accounting records
that are sufficient to show and explain the company's and the
group's transactions and disclose with reasonable accuracy at any
time the financial position of the company and the group and enable
them to ensure that the financial statements comply with the
Companies Act 2006. They are also responsible for safeguarding the
assets of the company and the group and hence for taking reasonable
steps for the prevention and detection of fraud and other
irregularities.
The
Directors are responsible for the maintenance and integrity of the
corporate and financial information included on the Company's
website. Legislation in the United Kingdom governing the
preparation and dissemination of the financial statements may
differ from legislation in other jurisdictions.
STATEMENT AS TO DISCLOSURE OF
INFORMATION TO AUDITORS
So far as
the directors are aware, there is no relevant audit information (as
defined by Section 418 of the Companies Act 2006) of which the
Group's auditors are unaware, and each director has taken all the
steps that he ought to have taken as a director in order to make
himself aware of any relevant audit information and to establish
that the Group's auditors are aware of that information.
AUDITORS
The
auditors, RPG Crouch Chapman LLP, will be proposed for
re-appointment at the forthcoming Annual General
Meeting.
ON BEHALF OF THE
BOARD
-----------------------------
Stephen
Argent
Chief Financial
Officer
Date: 7
January 2025
AUDITORS'
REPORT
Qualified
Opinion
We have
audited the financial statements of S-Ventures PLC (the 'Company')
and its subsidiaries (the 'Group') for the period ended 31 December
2023 which comprise the Consolidated Statement of Comprehensive
Income, the Consolidated Statement of Financial Position, the
Statement of Financial Position, the Consolidated Statement of
Changes in Equity, the Statement of Changes in Equity, the
Consolidated Statement of Cash Flows, the Statement of Cash Flows
and notes to the financial statements, including a summary of
significant accounting policies. The financial reporting framework
that has been applied in their preparation is applicable law and UK
adopted international accounting standards and as regards the
Parent Company financial statements, as applied in accordance with
the provisions of the Companies Act 2006.
In our
opinion, except for the possible effects of the matter described in
the basis for qualified opinion section of our report:
·
the financial statements give
a true and fair view of the state of the Group's and of the Parent
Company's affairs as at 31 December 2023 and of the Group's loss
for the period then ended;
·
the Group financial statements
have been properly prepared in accordance with UK adopted
international accounting standards;
·
the Parent Company financial
statements have been properly prepared in accordance with UK
adopted international accounting standards and as applied in
accordance with the provisions of the Companies Act 2006,
and
·
The financial statements have
been prepared in accordance with the requirements of the Companies
Act 2006.
Basis for qualified
opinion
We were not
appointed as auditor of the group and company until after 31
December 2023 and thus did not observe the counting of physical
inventories at the end of the year. We were unable to satisfy
ourselves by alternative means concerning the inventory quantities
held by Pulsin Limited and Market Rocket Limited at 31 December
2023, which are included in the consolidated balance sheet at
£1,074,886, by using other audit procedures. Consequently, we were
unable to determine whether any adjustment to this amount was
necessary. Were any adjustment to the inventory balance to be
required, the strategic report would also need to be
amended.
We
conducted our audit in accordance with International Standards on
Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities
under those standards are further described in the Auditor's
responsibilities for the audit of the financial statements section
of our report. We are independent of the group in accordance with
the ethical requirements that are relevant to our audit of the
financial statements in the UK, including the FRC's Ethical
Standard as applied to listed entities, and we have fulfilled our
other ethical responsibilities in accordance with these
requirements. We believe that the audit evidence we have obtained
is sufficient and appropriate to provide a basis for our
opinion.
Material uncertainty related
to going concern
We draw
attention to Note 2.4 in the accounting policies, concerning the
Group's ability to continue as a going concern. The matters
explained in Note 2.4 indicate that the directors have prepared
working capital forecasts that indicate that the Group has
sufficient working capital, cash resources and credit facilities to
continue operating for the foreseeable future. These forecasts
anticipate the completion of a reverse takeover transaction in the
coming months. As at the date of approval of these financial
statements there are no legally binding agreements committing the
parties to the reverse takeover transaction. These events or
conditions along with the matters set forth in Note 2.4 indicate
the existence of a material uncertainty which may cast significant
doubt over the Group's ability to continue as a going concern. Our
opinion is not modified in respect of this matter.
We have
highlighted going concern as a key audit matter. In auditing the
financial statements, we have concluded that the Directors' use of
the going concern basis of accounting in the preparation of the
financial statements is appropriate. Our evaluation of the
Directors' assessment of the Group and the Parent Company's ability
to continue to adopt the going concern basis of accounting
included:
·
Analysing the Directors'
cashflow forecast which forms the basis of their assessment that
the going concern basis of preparation remains appropriate for the
preparation of the Group and Company financial statements for a
period of at least twelve months from the date of approval of these
financial statements;
·
Assessing the assumptions
included within the cashflow forecast and where available agreeing
these costs to other evidence obtained during the course of our
audit work is in line with our expectations;
·
Obtaining details of
successful fundraising since the year end;
·
Discussing with Management and
the Board the Group's strategy to continue fundraising, and any
alternative sources of funds available to the Group; and
·
Reviewing and considering the
adequacy of the disclosure within the financial statements relating
to the Directors' assessment of the going concern basis of
preparation.
Our
responsibilities and the responsibilities of the directors with
respect to going concern are described in the relevant sections of
this report.
Our approach to the
audit
In planning
our audit, we determined materiality and assessed the risks of
material misstatement in the financial statements. In particular,
we looked at where the directors made subjective judgements, for
example in respect of significant accounting estimates. As in all
of our audits, we also addressed the risk of management override of
internal controls, including evaluating whether there was evidence
of bias by the directors that represented a risk of material
misstatement due to fraud.
We tailored
the scope of our audit to ensure that we performed sufficient work
to be able to issue an opinion on the financial statements as a
whole, taking into account the structure of the Company, the
accounting processes and controls, and the industry in which they
operate.
Key Audit
Matters
Key audit
matters are those matters that, in our professional judgement, were
of most significance in our audit of the financial statements of
the current period and include the most significant assessed risks
of material misstatement we identified (whether or not due to
fraud), including those which had the greatest effect on: the
overall audit strategy; the allocation of resources in the audit;
and directing the efforts of the engagement team. These matters
were addressed in the context of our audit of the financial
statements as a whole, and in forming our opinion thereon, and we
do not provide a separate opinion on these matters. The use of the
going concern basis of accounting was assessed as a key audit
matter and has already been covered in an earlier section of this
report.
In addition
to the matter described in the basis for qualified opinion section,
we have determined the matters described below to be the key audit
matters to be communicated in our report.
Key audit
matter
|
How our work addressed this
matter
|
Management override of
controls
Management
override of controls is a presumed risk of fraud under the
International Auditing Standards.
Professional standards require us to communicate the fraud
risk from management override of controls as significant because
management is typically in a unique position to perpetrate fraud
because of its ability to manipulate accounting records and prepare
fraudulent financial statements by overriding controls that
otherwise appear to be operating effectively.
|
Our audit work
included:
·
Obtaining a list of manual
journals entered into the accounting system in the year and
reviewing a sample of these against a range of different
criteria.
·
Reviewing management
estimates, judgements and significant accounting policies for undue
bias in the financial statements.
·
Develop an understanding of
the internal financial procedures, systems and controls in place
across the Group.
·
Reviewed unadjusted audit
differences and proposed audit adjustments for indications of
management bias or deliberate misstatement.
|
Revenue
recognition
Revenue
recognition is a presumed risk of fraud under the International
Auditing Standards.
The Group
has revenue from a variety of sources including food manufacturing
and online marketing.
|
Our audit work
included:
·
Obtaining an understanding of
the sales systems in place across the Group.
·
Testing cut-off for revenue by
identifying dispatches of inventories around the year end and
verifying recognition of revenue is consistent with IFRS 15:
Revenue.
·
Using a larger sample size for
transaction testing of revenue to address the elevated
risk
·
Reviewing accounting policies
and disclosures.
|
Valuation of investments in
subsidiaries and associated undertakings
The Parent
Company, and S-Ventures Acquisitions Limited, an intermediate
holding company within the Group, holds investments in subsidiaries
and associated undertakings.
The
carrying value of investments are ultimately dependent on the
performance of those subsidiaries and associates.
The Group
companies have receivable and payable balances with each other that
are material on a Group basis.
The
valuation and recoverability of these amounts is therefore a risk,
on the basis that their values may be impaired or not fully
recoverable.
|
Our audit work
included:
·
Obtaining documentary evidence
to support the ownership of subsidiaries.
·
Considered the valuation of
investments in the context of the net assets and profitability of
the companies.
·
Reviewed other evidence from
internal and external sources to support the valuation of
subsidiary companies.
·
Reviewed management's
impairment assessments and the completeness of provisions made
against investments in discontinued or aborted
associates.
|
Valuation of intangible
assets
The
consolidated balance sheet includes £3.5m of goodwill, £7.6m of
acquired intangible assets arising from the acquisition of Juvela
Limited, and £613K of internally developed assets with respect of
Pulsin Limited.
These
intangible assets represent a substantial proportion of the Group's
net assets. Valuing the intangible assets is a subjective exercise
and significant assumptions are required, which have a material
impact on the valuation of those intangible assets.
|
Our audit work
included:
·
Obtained management's PPA
allocation assessment and reviewed the valuation methods for
reasonableness.
·
Ensured that internally
generated assets are capitalised and measured in accordance with
recognition criteria in IAS 38. Challenged the continued existence
of intangible assets based on internal and external evidence of
commercial and technical feasibility via inquiry and discussion
with management.
·
Reviewed and assessed the
assumptions implicit within impairment reviews for
reasonableness.
|
Valuation of
inventories
As
described in note 2.15 the Group values inventory at the lower of
cost and realisable value, and provides for obsolete and slow
moving inventory.
By its
nature, the inventory held by the Group is perishable, which puts
increased importance on the Group's processes for identifying
inventory that needs to be provided for or written off.
|
Our audit work
included:
·
Developing an understanding of
the stock valuation policies in place across the Group.
·
Testing a sample of inventory
items to the underlying costs involved in the purchase and
production of inventory.
·
Testing a sample of inventory
items to sales after the year end to support the valuation in the
financial statements.
·
Reviewing stock provisions at
the year end, and reviewing write-offs after the year end to assess
whether subsequent inventory write-offs revealed additional
evidence of conditions prevailing at the year end.
·
Challenging management's
assumptions as to recoverability of packaging stock.
|
Our application of
materiality
We apply
the concept of materiality both in planning and performing our
audit, and in evaluating the effect of misstatements. We consider
materiality to be the magnitude by which misstatements, including
omissions, could influence the economic decisions of reasonable
users that are taken on the basis of the financial
statements.
In order to
reduce to an appropriately low level the probability that any
misstatements exceed materiality, we use a lower materiality level,
performance materiality, to determine the extent of testing needed.
Importantly, misstatements below these levels will not necessarily
be evaluated as immaterial as we also take account of the nature of
identified misstatements, and the particular circumstances of their
occurrence, when evaluating their effect on the financial
statements as a whole.
We consider
turnover to be the most significant determinant of the Group's
financial performance used by the users of the financial
statements, and gross assets to be the most significant determinant
of the Parent Company's financial performance. We have based
materiality for the Group on 0.75% of turnover and 1.5% of gross
assets for the Parent Company. Overall materiality was therefore
set at £295,000 for the Group, and at £198,000 for the Parent
Company. Performance materiality was set at a threshold between 50%
and 75% of materiality depending on the determined audit risk of
the financial statement area in question. Significant audit risk
areas (revenue recognition and management override) were audited to
a 50% performance materiality threshold with remaining areas
subject to a 75% performance materiality threshold.
We agreed
with the Audit Committee that we would report on all differences in
excess of 5% of materiality relating to the financial statements.
We also report to the Audit Committee on financial statement
disclosure matters identified when assessing the overall
consistency and presentation of the financial
statements.
Other
information
The other
information comprises the information included in the annual
report, other than the financial statements and our auditor's
report thereon. The directors are responsible for the other
information contained within the annual report. Our opinion
on the financial statements does not cover the other information
and, except to the extent otherwise explicitly stated in our
report, we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our
responsibility is to read the other information and, in doing so,
consider whether the other information is materially inconsistent
with the financial statements or our knowledge obtained in the
audit or otherwise appears to be materially misstated. If we
identify such material inconsistencies or apparent material
misstatements, we are required to determine whether there is a
material misstatement in the financial statements or a material
misstatement of the other information. If, based on the work we
have performed, we conclude that there is a material misstatement
of this other information, we are required to report that fact. We
have nothing to report in this regard.
Opinions on other matters
prescribed by the Companies Act 2006
In our
opinion, based on the work undertaken in the course of the
audit:
·
the information given in the
Strategic Report and the Directors' Report for the financial year
for which the financial statements are prepared is consistent with
the financial statements; and
·
the Strategic Report and the
Directors' Report have been prepared in accordance with applicable
legal requirements.
·
The part of the Director's
Remuneration Report to be audited has been properly prepared in
accordance with the Companies Act 2006.
Matters on which we are
required to report by exception
Except for
the matter described in the basis for qualified opinion section of
our report, in the light of the knowledge and understanding of the
Company and its environment obtained in the course of the audit, we
have not identified material misstatements in the Strategic Report,
the Directors' Report or the Director's Remuneration
Report.
Arising
solely from the limitation on the scope of our work relating to
inventory, referred to as above:
·
we have not obtained all the
information and explanations that we considered necessary for the
purpose of our audit; and
·
we were unable to determine
whether adequate accounting records have been kept.
We have
nothing to report in respect of the following matters in relation
to which the Companies Act 2006 requires us to report to you if, in
our opinion:
·
returns adequate for our audit
have not been received from branches not visited by us;
or
·
the financial statements are
not in agreement with the accounting records and returns;
or
·
certain disclosures of
directors' remuneration specified by law are not made.
Responsibilities of
directors
As
explained more fully in the directors' responsibilities statement
set out on page XX to XX the directors are responsible for the
preparation of the financial statements and for being satisfied
that they give a true and fair view, and for such internal control
as the directors determine is necessary to enable the preparation
of financial statements that are free from material misstatement,
whether due to fraud or error.
In
preparing the financial statements, the directors are responsible
for assessing the company's ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and
using the going concern basis of accounting unless the directors
either intend to liquidate the company or to cease operations, or
have no realistic alternative but to do so.
Those
charged with governance are responsible for overseeing the
Company's financial reporting process.
Auditor's responsibilities
for the audit of the financial statements
Our
objectives are to obtain reasonable assurance about whether the
financial statements as a whole are free from material
misstatement, whether due to fraud or error, and to issue our
opinion in an auditor's report. Reasonable assurance is a high
level of assurance, but does not guarantee that an audit conducted
in accordance with ISAs (UK) will always detect a material
misstatement when it exists. Misstatements can arise from fraud or
error and are considered material if, individually or in aggregate,
they could reasonably be expected to influence the economic
decisions of users taken on the basis of the financial
statements.
Irregularities, including fraud, are instances of
non-compliance with laws and regulations. We design procedures in
line with our responsibilities, outlined above, to detect material
misstatements in respect of irregularities, including fraud. The
extent to which our procedures are capable of detecting
irregularities, including fraud, is detailed below:
·
Enquiries of management,
including obtaining and reviewing supporting documentation
concerning the Company's policies and procedures relating
to;
-
Identifying, evaluating and
complying with laws and regulations and whether they were aware of
any instances of non-compliance
-
Detecting to and responding to the
risks of fraud and whether they have knowledge of any actual,
suspected or alleged fraud
·
Discussions amongst the
engagement team regarding how and where fraud might occur in the
financial statements and any potential indicators of
fraud.
We also
obtained an understanding of the legal and regulatory framework
that the Group operates in, focusing on provisions of those laws
and regulations that had a direct effect on the determination of
material amounts and disclosures included within the financial
statements. The key laws and regulations we considered in this
context included the UK Companies Act and IFRS.
In addition
we considered provisions of other laws and regulations that do not
have a direct effect on the financial statements but compliance
with which may be fundamental to the Group and Company's ability to
operate or to avoid a material penalty. These included food safety
regulations, health and safety regulations, employment law, data
protection regulations and general trading laws in the
UK.
As a result
of these procedures we consider the particular areas that were
susceptible to misstatement due to fraud were in respect of revenue
recognition, management override of controls, investment valuation,
intangible assets valuation, and inventories valuation.
Our
procedures to respond to these risks identified included the
following;
·
Reviewing the financial
statement disclosures and testing these to supporting documentation
to assess compliance with provisions of relevant laws and
regulations described as having a direct effect on the financial
statements,
·
Enquiring with management
concerning actual and potential litigation claims,
·
Performing analytical
procedures to identify any unusual or unexpected relationships that
may indicate risks of material misstatement due to
fraud,
·
Agreeing investment and
intangible valuations to supporting documentation and
recalculating,
·
Reviewing management
impairment assessments and challenging assumptions made to ensure
valuations of intangibles and investments are
reasonable,
·
Reviewing the Group's
methodology for valuing inventories, particularly in relation to
production overheads absorbed into inventory at the year end, and
reviewing the adequacy of provisions for slow moving
inventory,
·
Reviewing board minutes and
legal and professional fees during the year and any subsequent to
the year end to identify any potential litigation not previously
disclosed,
·
Communicating with component
auditors to ensure that the engagement team collectively had the
appropriate capabilities to identify or recognise non-compliance
with laws and regulations across the Group,
·
In addressing the risk of
fraud through management override of controls, testing the
appropriateness of journal entries and other adjustments for
evidence of management override/bias and agreeing these to
supporting documentation, and
·
Assessing whether the
judgements made in making accounting estimates are indicative of a
potential bias and evaluating the rationale of any significant
transactions that are deemed unusual or outside of the normal
course of the Company's operations.
Because of
the inherent limitations of an audit, there is a risk that we will
not detect all irregularities, including those leading to a
material misstatement in the financial statements or non-compliance
with regulation. This risk increases the more that compliance with
a law or regulation is removed from the events and transactions
reflected in the financial statements, as we will be less likely to
become aware of instances of non-compliance. The risk is also
greater regarding irregularities occurring due to fraud rather than
error, as fraud involves intentional concealment, forgery,
collusion, omission or misrepresentation.
A further
description of our responsibilities for the audit of the financial
statements is located on the Financial Reporting Council's website
at: www.frc.org.uk/auditorsresponsibilities. This description forms
part of our Auditor's Report.
Other matters that we are
required to address
We were
appointed on 21 June 2024 and this is the first year of our
engagement as auditors for the Group and Company.
We confirm
that we are independent of the Group and Company and have not
provided any prohibited non-audit services, as defined by the
Ethical Standard issued by the Financial Reporting Council as
applied to listed public interest entities, and we have fulfilled
our ethical responsibilities in accordance with these
requirements.
Our audit
report is consistent with our additional report to the Audit
Committee explaining the results of our audit.
Use of our
report
This report
is made solely to the Company's members, as a body, in accordance
with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work
has been undertaken so that we might state to the Company's members
those matters we are required to state to them in an auditor's
report and for no other purpose. To the fullest extent permitted by
law, we do not accept or assume responsibility to anyone other than
the Company and the Company's members, as a body, for our audit
work, for this report, or for the opinions we have
formed.
Paul Randall FCA (Senior
Statutory Auditor)
For and on behalf of RPG
Crouch Chapman LLP
Chartered
Accountants
Registered
Auditor
40
Gracechurch Street
London
EC3V
0BT
7 January
2025
|
Note
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Continuing
operations
|
|
|
|
|
Revenue
|
4
|
19,658
|
|
7,628
|
Cost of
sales
|
|
(10,300)
|
|
(5,040)
|
Gross
profit
|
|
9,358
|
|
2,588
|
Other
operating income
|
5
|
90
|
|
45
|
Gain /
(loss) on disposal
|
|
(111)
|
|
-
|
Gain on
settlement of loan notes
|
7
|
-
|
|
645
|
Operating
expenses
|
|
(9,929)
|
|
(4,573)
|
Earnings before interest,
taxation, depreciation and amortisation
|
|
(592)
|
|
(1,295)
|
Depreciation, amortisation and impairment
|
|
(2,210)
|
|
(862)
|
Finance
costs - net
|
8
|
(1,243)
|
|
(73)
|
Loss before
taxation
|
9
|
(4,045)
|
|
(2,230)
|
Income
tax
|
11
|
(399)
|
|
(152)
|
Loss for the period -
continuing operations
|
|
(4,444)
|
|
(2,382)
|
Loss after
tax from discontinued operations
|
30
|
(2,191)
|
|
(1,074)
|
Loss for the
period
|
|
(6,635)
|
|
(3,456)
|
Loss attributable
to:
|
|
|
|
|
Owners of
the parent
|
|
(6,597)
|
|
(3,323)
|
Non-controlling interests
|
|
(38)
|
|
(133)
|
Loss for the
period
|
|
(6,635)
|
|
(3,456)
|
Other
comprehensive income
|
|
-
|
|
-
|
Total comprehensive loss for
the period
|
|
(6,635)
|
|
(3,456)
|
Total comprehensive loss
attributable to:
|
|
|
|
|
Owners of
the parent - continuing
|
|
(4,406)
|
|
(2,249)
|
Owners of
the parent - discontinuing
|
|
(2,191)
|
|
(1,074)
|
Non-controlling interests
|
|
(38)
|
|
(133)
|
|
|
(6,635)
|
|
(3,456)
|
|
|
|
|
|
Basic
earnings per share - pence
|
13
|
(5.04)
|
|
(2.92)
|
The accompanying
notes on pages 34 to 65 form part of the financial
statements.
GROUP
|
Note
|
As at 31 December
2023
£'000
|
|
As at 30 September
2022
£'000
|
ASSETS
|
|
|
|
|
NON-CURRENT
ASSETS
|
|
|
|
|
Goodwill
|
16
|
3,463
|
|
3,898
|
Intangible
assets
|
17
|
7,619
|
|
2,990
|
Property,
plant and equipment
|
18
|
2,204
|
|
2,027
|
Right of
use asset
|
27
|
1,233
|
|
1,419
|
Investments
|
19
|
30
|
|
30
|
Total non-current
assets
|
|
14,549
|
|
10,364
|
CURRENT
ASSETS
|
|
|
|
|
Inventories
|
20
|
1,856
|
|
1,647
|
Trade and
other receivables
|
21
|
2,882
|
|
2,599
|
Cash and
cash equivalents
|
22
|
305
|
|
1,782
|
Total current
assets
|
|
5,043
|
|
6,028
|
Assets
from discontinued operations
|
30
|
60
|
|
-
|
TOTAL
ASSETS
|
|
19,652
|
|
16,392
|
|
|
|
|
|
EQUITY
|
|
|
|
|
SHAREHOLDERS
EQUITY
|
|
|
|
|
Called up
share capital
|
23
|
132
|
|
126
|
Share
premium
|
23
|
14,708
|
|
13,509
|
Share
based payment reserve
|
24
|
8
|
|
11
|
Consideration for investment
|
24
|
112
|
|
112
|
Retained
deficit
|
|
(10,825)
|
|
(4,228)
|
Total
equity
|
|
4,135
|
|
9,530
|
Non-controlling interests
|
|
(72)
|
|
(34)
|
TOTAL
EQUITY
|
|
4,063
|
|
9,496
|
GROUP
|
Note
|
As at 31 December
2023
£'000
|
|
As at 30 September
2022
£'000
|
LIABILITIES
|
|
|
|
|
NON-CURRENT
LIABILITIES
|
|
|
|
|
Financial liabilities:
|
|
|
|
|
Interest bearing loans and borrowings
|
26
|
6,369
|
|
192
|
Lease liability
|
29
|
336
|
|
1,686
|
Provision
|
|
440
|
|
-
|
Total non-current
liabilities
|
|
7,145
|
|
1,878
|
CURRENT
LIABILITIES
|
|
|
|
|
Trade and
other payables
|
25
|
5,328
|
|
3,263
|
Financial
liabilities - borrowings
|
|
|
|
|
Bank overdrafts
|
26
|
-
|
|
276
|
Interest bearing loans and borrowings
|
26
|
1,582
|
|
722
|
Lease
liability
|
29
|
1,340
|
|
434
|
Tax
payable
|
11
|
-
|
|
323
|
Total current
liabilities
|
|
8,250
|
|
5,018
|
Liabilities from discontinued operations
|
30
|
194
|
|
-
|
TOTAL
LIABILITIES
|
|
15,589
|
|
6,896
|
TOTAL EQUITY AND
LIABILITIES
|
|
19,652
|
|
16,392
|
The financial
statements were approved by the Board of Directors and authorised
for issue on 7 January 2025 and were signed on its behalf
by:
____________________
S Argent -
Director
The accompanying
notes on pages 34 to 65 form part of the financial
statements.
COMPANY
|
Note
|
As at 31 December
2023
£'000
|
|
As at 30 September
2022
£'000
|
ASSSETS
|
|
|
|
|
NON-CURRENT
ASSETS
|
|
|
|
|
Property,
plant and equipment
|
18
|
17
|
|
22
|
Investments
|
19
|
3,456
|
|
8,403
|
|
|
3,473
|
|
8,425
|
CURRENT
ASSETS
|
|
|
|
|
Trade and
other receivables
|
21
|
5,683
|
|
3,064
|
Cash and
cash equivalents
|
22
|
22
|
|
1,723
|
|
|
5,705
|
|
4,787
|
|
|
|
|
|
TOTAL
ASSETS
|
|
9,178
|
|
13,212
|
|
|
|
|
|
EQUITY
|
|
|
|
|
SHAREHOLDERS
EQUITY
|
|
|
|
|
Called up
share capital
|
23
|
132
|
|
126
|
Share
premium
|
23
|
14,708
|
|
13,509
|
Share
based payment reserve
|
24
|
8
|
|
11
|
Consideration for investment
|
24
|
112
|
|
112
|
Retained
deficit
|
|
(10,783)
|
|
(1,819)
|
TOTAL
EQUITY
|
|
4,177
|
|
11,939
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
NON-CURRENT
LIABILITIES
|
|
|
|
|
Borrowings
|
26
|
1,709
|
|
-
|
Provisions
|
|
354
|
|
-
|
|
|
2,063
|
|
-
|
CURRENT
LIABILITIES
|
|
|
|
|
Borrowings
|
26
|
402
|
|
-
|
Trade and
other payables
|
27
|
2,536
|
|
1,273
|
|
|
2,938
|
|
1,273
|
TOTAL
LIABILITIES
|
|
5,001
|
|
1,273
|
|
|
|
|
|
TOTAL EQUITY AND
LIABILITIES
|
|
9,178
|
|
13,212
|
The Company has
elected to take the exemption under Section 408 of the Companies
Act 2006 from presenting the Parent Company profit and loss
account. The Parent Company loss for the period was £8,964,000
(2022: loss of £1,350,000).
The financial
statements were approved by the Board of Directors and authorised
for issue on 7 January 2025 and were signed on its behalf
by:
____________________
S Argent -
Director
The accompanying
notes on pages 34 to 65 form part of the financial
statements.
GROUP
|
Note
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Cash flows from operating
activities
|
|
|
|
|
Loss
before income tax
|
|
(6,635)
|
|
(3,257)
|
Adjustments for:
|
|
|
|
|
Amortisation, depreciation and impairment charges
|
|
1,864
|
|
937
|
Profit on
disposal of fixed assets
|
|
-
|
|
(3)
|
Gain on
settlement of loan notes
|
|
-
|
|
(645)
|
Impairment
of goodwill
|
|
1,657
|
|
569
|
Finance
costs
|
|
1,254
|
|
94
|
Finance
income
|
|
(6)
|
|
(16)
|
Tax
paid
|
|
-
|
|
(126)
|
Interest
paid
|
|
(956)
|
|
(73)
|
Lease
interest paid
|
|
(33)
|
|
(41)
|
|
|
(2,855)
|
|
(2,561)
|
Changes in working
capital:
|
|
|
|
|
Increase
in inventory
|
|
70
|
|
(637)
|
Decrease /
(increase) in trade and other receivables
|
|
1,190
|
|
(99)
|
(Decrease)
/ increase in trade and other payables
|
|
192
|
|
662
|
Net cash from operating
activities
|
|
(1,403)
|
|
(2,635)
|
|
|
|
|
|
Cash flows from investing
activities
|
|
|
|
|
Cash
acquired on acquisition
|
|
485
|
|
-
|
Acquisition of subsidiary undertakings
|
|
(7,709)
|
|
(100)
|
Purchase
of intangible fixed assets
|
|
(201)
|
|
-
|
Purchase
of tangible fixed assets
|
|
(15)
|
|
(366)
|
Interest
received
|
|
1
|
|
14
|
Net cash from investing
activities
|
|
(7,439)
|
|
(452)
|
|
|
|
|
|
Cash flows from financing
activities
|
|
|
|
|
Payment of
lease liabilities
|
|
(611)
|
|
(309)
|
Net
proceeds on borrowings
|
|
7,210
|
|
(237)
|
Amount
introduced / (withdrawn) by directors
|
|
690
|
|
172
|
Proceeds
from issue of shares
|
|
352
|
|
5,073
|
Net cash from financing
activities
|
|
7,641
|
|
4,699
|
|
|
|
|
|
(Decrease) / increase in cash
and cash equivalents
|
|
(1,201)
|
|
1,612
|
Cash and
cash equivalents at beginning of the year
|
|
1,506
|
|
(106)
|
|
|
|
|
|
Cash and cash equivalents at
end of the year
|
|
305
|
|
1,506
|
Note the cash and
cash equivalents balance includes the bank overdraft of £nil (2022:
£276,000)
The accompanying
notes on pages 34 to 65 form part of the financial
statements.
COMPANY
|
Note
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Cash flows from operating
activities
|
|
|
|
|
Loss
before income tax
|
|
(8,964)
|
|
(1,245)
|
Adjustments for:
|
|
|
|
|
Depreciation and impairment charges
|
|
6,465
|
|
4
|
Impairment
of subsidiary investment
|
|
834
|
|
305
|
Gain on
settlement of loan notes
|
|
-
|
|
(645)
|
Finance
costs
|
|
159
|
|
(29)
|
Finance
income
|
|
(1)
|
|
(16)
|
Interest
paid
|
|
(159)
|
|
-
|
|
|
(1,666)
|
|
(1,626)
|
Changes in working
capital:
|
|
|
|
|
Increase
in trade and other receivables
|
|
(2,278)
|
|
(2,221)
|
(Decrease)
/ increase in trade and other payables
|
|
519
|
|
324
|
Net cash from operating
activities
|
|
(3,425)
|
|
(3,523)
|
|
|
|
|
|
Cash flows from investing
activities
|
|
|
|
|
Purchase
of tangible fixed assets
|
|
-
|
|
(22)
|
Net
investment in subsidiaries
|
|
(1,467)
|
|
-
|
Purchase
of fixed asset investments
|
|
-
|
|
(100)
|
Interest
received
|
|
-
|
|
16
|
Net cash from investing
activities
|
|
(1,467)
|
|
(106)
|
|
|
|
|
|
Cash flows from financing
activities
|
|
|
|
|
Amount
introduced / (withdrawn) by directors
|
|
690
|
|
172
|
Proceeds
from borrowings
|
|
1,296
|
|
|
Proceeds
from issue of shares
|
|
1,205
|
|
5,073
|
Net cash from financing
activities
|
|
3,191
|
|
5,245
|
|
|
|
|
|
(Decrease) / increase in cash
and cash equivalents
|
|
(1,701)
|
|
1,616
|
Cash and
cash equivalents at beginning of the year
|
|
1,723
|
|
107
|
|
|
|
|
|
Cash and cash equivalents at
end of the year
|
|
22
|
|
1,723
|
Major non-cash
transactions
During the period the
following non-cash share issues took place:
14 December 2022
Juvela Limited Acquisition
£5,000,000
During the prior year
the following non-cash share issues took place:
1 November 2021
Shares issued for consultancy
services
£50,000
17 February 2022
For trade and asset
purchases
£225,000
11 April 2022
Market Rocket Ltd Acquisition
£673,000
13 June 2022
Convertible loan note settlement
£1,012,000
The accompanying
notes on pages 34 to 65 form part of the financial
statements.
1
GENERAL INFORMATION
S-Ventures
PLC is a private company, registered in England and Wales. The
company's registered number and registered office address can be
found on the General Information page. The Company's shares are
traded on AQSE (ticker SVEN) and the US OTCQB Venture
market.
The
principal activities for the group is to invest in and take
majority ownership in wellness and consumer brand businesses, to
build a portfolio of brands, share resources to accelerate growth
and efficiencies and add value by the provision of capital and
management expertise.
The
consolidated financial information was approved for issue by the
Board of Directors on 7 January 2025.
2
ACCOUNTING POLICIES
2.1
Basis of preparation
These
financial statements have been prepared in accordance with
UK-adopted international accounting standards and with those parts
of the Companies Act 2006 applicable to companies reporting under
IFRS.
The
financial statements have been prepared on the historical cost
basis, except for certain financial assets and liabilities which
are carried at fair value or amortised cost as
appropriate.
The
financial statements are presented in £ unless otherwise stated
(rounded to the nearest £'000), which is the Company's functional
currency and the Group and Company's presentational
currency.
During the
period the Group changed its accounting period to 31 December to be
co-terminous with that of its largest subsidiary, Juvela Limited.
Therefore, the results for the current period are for the 15 months
ended 31 December 2023, with the comparatives being for the year
ended 30 September 2022.
2.2
New standards, amendments and
interpretations
There has been no
impact on The Group as a result of adopting any of the new and
amended standards and interpretations issued by the International
Accounting Standards Board that are relevant to its operations and
effective for accounting periods commencing on or after 1 October
2022.
2.3
New standards and interpretations not yet
adopted
At the
date of approval of these financial statements, the following
standards and interpretations which have not been applied in these
financial statements were in issue but not yet effective (and in
some cases have not yet been adopted by the UK):
Standard
|
Impact on initial
application
|
Effective
date
|
IFRS S1
|
General
requirements for disclosure of sustainability-related financial
information
Climate-related disclosures
|
1 January
2024
|
IFRS S2
|
General
requirements for disclosure of sustainability-related financial
information
|
1 January
2024
|
IFRS
7
(amendments)
|
Amendments
regarding supplier finance arrangements
|
1 January
2024
|
IFRS 16
(amendments)
|
Measurement
of sale and leaseback transactions
|
1 January
2024
|
IAS 1
(amendments)
|
Presentation of Financial Statements: classification of
liabilities
|
1 January
2024
|
IAS 1
(amendments)
|
Non-Current
Liabilities with Covenants
|
1 January
2024
|
IAS 7
(amendments)
|
Supplier
finance arrangements
|
1 January
2024
|
The effect
of these new and amended Standards and Interpretations which are in
issue but not yet mandatorily effective is not expected to be
material.
2.4
Going concern
As
disclosed in the Chairman's Statement and CEO's Report, the
directors sought to raise funding of £2.5 million in the last
quarter of 2023. This was needed to meet the company's
obligations to Hero for the final deferred payment for the
acquisition of Juvela, to support the central costs of a listed
business and, to a lesser extent, to support trading.
With equity
markets not offering liquidity or value, a total of £3 million of
debt facilities was raised in the following months, including
£1million of facilities from a Middle Eastern family office and
£2million of facilities from Riverfort Global Opportunities plc
("RGO"). This was alongside the announcement of RGO's
potential acquisition of the company's active trading subsidiaries
and novation of liabilities.
The
directors continue to progress this important potential transaction
(the "Transaction") in close collaboration with the Board of RGO.
The Transaction that is proposed is intended to raise enough
capital to settle all of the parent companies loans, leaving only
the subsidiary loan in Juvela and approximately halving the
financial debt carried by our group of businesses. The
subsidiary loan at Juvela, which was used for its acquisition, has
been reduced significantly through operating cashflow and, as at
the date of this report, the amount owed to Shawbrook is now
approximately £4m.
The
directors recognise that additional capital is required to ensure
that the company can continue to discharge its liabilities as they
fall due and have concluded that the funding requirements
represents a material uncertainty that casts significant doubt upon
the company's ability to continue as a going concern.
However, the directors believe that the transaction outlined
above will conclude successfully when these accounts are
issued.
Accordingly, the Directors have concluded that it is
reasonable to adopt a going concern basis in preparing these
financial statements. This is based on a reasonable expectation
that the Group has adequate resources to continue in operational
existence for at least twelve months from the date of signing of
these accounts.
2.5
Basis of consolidation
Where the
company has control over an investee, it is classified as a
subsidiary. The company controls an investee if all three of the
following elements are present: power over the investee, exposure
to variable returns from the investee, and the ability of the
investor to use its power to affect those variable returns. Control
is reassessed whenever facts and circumstances indicate that there
may be a change in any of these elements of control.
The
consolidated financial statements present the results of the
company and its subsidiaries as if they formed a single entity.
Intercompany transactions and balances between group companies are
therefore eliminated in full. All subsidiaries either have or are
in the process of changing their accounting period ends to a
reporting date of 31 December.
The
consolidated financial statements incorporate the results of
business combinations using the acquisition method. In the
statement of financial position, the acquiree identifiable assets
and liabilities are initially recognised at their fair values at
the acquisition date.
The
results of acquired operations are included in the consolidated
statement of comprehensive income from the date on which control is
obtained. They are deconsolidated from the date on which control
ceases.
2.6
Business combinations
Acquisitions of businesses are accounted for using the
acquisition method. The consideration transferred in a business
combination is measured at fair value, which is calculated as the
sum of the acquisition-date fair values of assets transferred by
the Group, liabilities incurred by the Group to the former owners
of the acquiree and the equity interest issued by the Group in
exchange for control of the acquiree. Acquisition-related costs are
recognised in profit or loss as incurred. At the acquisition date,
the identifiable assets (both tangible and intangible) acquired and
the liabilities assumed are recognised at their fair value at the
acquisition date, except that deferred tax assets or liabilities
and assets or liabilities related to employee benefit arrangements
are recognised and measured in accordance with IAS 12 and IAS 19
respectively.
Goodwill
is measured as the excess of the sum of the consideration
transferred, the amount of any non-controlling interests in the
acquiree, and the fair value of the acquiree's previously held
equity interest in the acquiree (if any) over the net of the
acquisition-date amounts of the identifiable assets acquired and
the liabilities assumed. In the case of asset acquisition, it is
the excess of the sum of the consideration transferred over the net
of the acquisition date amounts of the identifiable assets acquired
and the liabilities assumed.
When the
consideration transferred by the Group in a business combination
includes a contingent consideration arrangement, the contingent
consideration is measured at its acquisition-date fair value and
included as part of the consideration transferred in a business
combination. Changes in fair value of the contingent consideration
that qualify as measurement period adjustments are adjusted
retrospectively, with corresponding adjustments against goodwill.
Measurement period adjustments are adjustments that arise from
additional information obtained during the measurement period
(which cannot exceed one year from the acquisition date) about
facts and circumstances that existed at the acquisition
date.
If the
initial accounting for a business combination is incomplete by the
end of the reporting period in which the combination occurs, the
Group reports provisional amounts for the items for which the
accounting is incomplete. Those provisional amounts are adjusted
during the measurement period or additional assets or liabilities
are recognised, to reflect new information obtained about facts and
circumstances that existed as of the acquisition date that, if
known, would have affected the amounts recognised as of that
date.
2.7
Associates
Associates
are all entities over which the Group has significant influence but
not control or joint control. This is generally the case where the
Group holds between 20% and 50% of the voting rights. Investments
in associates are accounted for using the equity method of
accounting.
Under the
equity method of accounting, the investments are initially
recognised at cost, including any directly attributable transaction
costs, and adjusted thereafter to recognise the Group's share of
the post-acquisition profits or losses of the investee in profit or
loss. The Group's share of movements in other comprehensive income
of the investee are recognised in other comprehensive income.
Dividends received or receivable from associates are recognised as
a reduction in the carrying amount of the investment.
Where the
Group's share of losses in an equity accounted investment equals or
exceeds its interest in the entity, the Group does not recognise
further losses, unless it has incurred obligations or made payments
on behalf of the other entity.
2.8
Revenue recognition
Revenue is
recognised at the fair value of the consideration received or
receivable for goods and services provided in the normal course of
business and is shown net of VAT and other sales related taxes. The
fair value of consideration takes into account trade discounts,
settlement discounts and volume rebates.
Performance obligations and timing of revenue
recognition:
Goods
The
majority of Group revenue is derived from selling goods with
revenue recognised at a point in time when control of the goods has
transferred to the customer. This is generally when the goods are
delivered to the customer. There is limited judgement needed in
identifying the point control passes: once physical delivery of the
products to the agreed location has occurred, the Group no longer
has physical possession, usually it will have a present right to
payment. Consideration is received in accordance with agreed terms
of sale.
Determining the contract price:
The Group
revenue is derived from:
a)
sale of goods with fixed price lists and therefore the
amount of revenue to be earned from each transaction is determined
by reference to those fixed prices; or
b)
Individual identifiable contracts, where the price is
defined
Allocating
amounts to performance obligations:
For most
sales, there is a fixed unit price for each product sold.
Therefore, there is no judgement involved in allocating the price
to each unit ordered.
Services
Revenue is
recognised on technical services over time as services are rendered
and performance obligations are satisfied
2.9
Cash and cash equivalents
Cash
represents cash in hand and deposits held on demand with financial
institutions. Cash equivalents are short-term, highly liquid
investments with original maturities of three months or less (as at
their date of acquisition). Cash equivalents are readily
convertible to known amounts of cash and subject to an
insignificant risk of change in that cash value.
In the
presentation of the Statement of Cash Flows, cash and cash
equivalents also include bank overdrafts. Any such overdrafts are
shown within borrowings under current liabilities on the Statement
of Financial Position.
2.10
Goodwill
Goodwill
represents the excess of the cost of a business combination over
the Group interest in the fair value of identifiable assets and
liabilities acquired. Cost comprises the fair value of assets
given, liabilities assumed, and equity instruments issued, plus the
amount of any non-controlling in the acquiree. Contingent
consideration is included in cost at its acquisition date fair
value.
Goodwill
is not amortised but it is tested for impairment annually, or more
frequently if events or changes in circumstances indicate that it
might be impaired and is carried at cost less accumulated
impairment losses.
2.11
Intangible assets
Intangible
assets acquired separately from a business are recognised at cost
and are subsequently
measured
at cost less accumulated amortisation and accumulated impairment
losses.
Identified
intangible assets arising on acquisition in business combinations
comprise; brand intellectual property and customer
relationships.
Amortisation is recognised so as to write off the cost or
valuation of assets less their residual values over
their
useful lives on the following bases:
-
Development costs
10
years
-
Brand intellectual property
10 years
-
Customer relationships
10
years
-
Contracts
10 years
2.12
Property, plant and equipment
Depreciation is provided at the following annual rates in
order to write off each asset over its estimated useful life or, if
held under a finance lease, over the lease term, whichever is the
shorter.
-
Lease hold additions
over
remaining lease term
-
Plant and machinery
25% and 10% on cost
-
Fixture and fittings
20% and 15% on cost
-
Computer equipment
33% and 25%
on cost
2.13
Financial instruments
IFRS 9
requires an entity to address the classification, measurement and
recognition of financial assets and liabilities.
a) Classification
The Group
classifies its financial assets in the following measurement
categories:
·
those to be measured at
amortised cost.
The
classification depends on the Group's business
model for managing the financial assets and the
contractual terms of the cash flows.
b) Recognition
Purchases
and sales of financial assets are recognised on trade date
(that is, the date on which the Group commits to purchase or sell
the asset). Financial assets are derecognised when the rights
to receive cash flows from the financial assets have expired
or have been transferred and the Group has transferred
substantially all the risks and rewards of
ownership.
c) Measurement
At initial
recognition, the Group measures a financial asset at its fair
value.
Debt
instruments
Amortised
cost: Assets that are held for collection of contractual cash
flows, where those cash flows represent solely payments of
principal and interest, are measured at amortised cost.
Interest income from these financial assets is included in
finance income using the effective interest rate method. Any gain
or loss arising on derecognition is recognised directly in profit
or loss and presented in other gains/(losses). Impairment losses
are presented as a separate line item in the statement of
comprehensive income.
d) Impairment
For trade
receivables, the Group applies the simplified approach permitted by
IFRS 9, which requires expected lifetime losses to be recognised
from initial recognition of the receivables. The Group's most
significant clients are public or regulated industry entities which
generally have high credit ratings or are of a high credit quality
due to the nature of the client.
Expected
credit losses are assessed on an individual customer basis, based
on the historical payment profiles of the customers, the current
and historic relationship with the customer, and the industry in
which the customer operates. There have been no impairments of
trade receivables in the periods.
2.14 Compound
instruments and borrowings
The
component parts of compound instruments are classified separately
as financial liabilities and equity in accordance with the
substance of the contractual agreement. At the date of issue, the
fair value of the liability component is estimated using the
prevailing market interest rate for similar debt instruments. This
amount is recorded as a liability on an amortised cost basis until
extinguished upon conversion or at the instrument's maturity date.
The equity component is determined by deducting the amount of the
liability component from the fair value of the compound instrument
as a whole. This is recognised and included in equity and is not
subsequently remeasured.
For
convertible debt where the parent has the option to convert the
loan principal into shares at its discretion, the principal is
included within equity. The only element that the company has an
obligation to settle in cash is the interest element, which is
included in liabilities.
2.15
Inventories
Inventories are valued at the lower of cost and net realisable
value, after making due allowance for obsolete and slow moving
items.
Inventories are stated at the lower of cost and estimated
selling price less costs to complete and sell. Cost comprises
direct materials and, where applicable, direct labour costs and
those overheads that have been incurred in bringing the stocks to
their present location and condition.
At each
reporting date, an assessment is made for impairment. Any excess of
the carrying amount of stocks over its estimated selling price less
costs to complete and sell is recognised as an impairment loss in
profit or loss. Reversals of impairment losses are also recognised
in profit or loss.
2.16 Research
and development
Research
expenditure is written off against profits in the year in which it
is incurred. Identifiable development expenditure is capitalised to
the extent that the technical, commercial and financial feasibility
can be demonstrated.
2.17 Foreign
currencies
Assets and
liabilities in foreign currencies are translated into sterling at
the rates of exchange ruling at the statement of financial position
date. Transactions in foreign currencies are translated into
sterling at the rate of exchange ruling at the date of transaction.
Exchange differences are taken into account in arriving at the
operating result.
2.18 Employee
benefit costs
The group
operates a defined contribution pension scheme. Contributions
payable to the group's pension scheme are charged to the income
statement in the period to which they relate
2.19
Taxation
The income
tax expense represents the sum of the tax currently payable and
deferred tax.
Current
tax
Current
taxes are based on the results shown in the financial statements
and are calculated according to local tax rules, using tax rates
enacted or substantially enacted by the statement of financial
position date.
Deferred
tax
Deferred
tax is the tax expected to be payable or recoverable on differences
between the carrying amounts of assets and liabilities in the
financial statements and the corresponding tax bases used in the
computation of taxable profit and is accounted for using the
liability method. Deferred tax liabilities are generally recognised
for all taxable temporary differences. Deferred tax assets are only
recognised to the extent that it is probable that taxable profits
will be available against which deductible temporary differences
can be utilised and there is reasonable certainty over the timing
of the taxable profits. Such assets and liabilities are not
recognised if the temporary difference arises from the initial
recognition of goodwill.
The
carrying amount of deferred tax assets is reviewed at each
reporting date and reduced to the extent that it is no longer
probable that sufficient taxable profits will be available to allow
all or part of the asset to be recovered.
Deferred
tax is calculated at the tax rates that are expected to apply in
the period when the liability is settled or the asset is
realised.
2.20
Leases
Leases are
recognised as a right-of-use asset and a corresponding lease
liability at the date at which the leased asset is available for
use by the Group.
Assets and
liabilities arising from a lease are initially measured on a
present value basis. Lease liabilities include the net present
value of the following lease payments:
-
Fixed payments (including
in-substance fixed payments), less any lease incentives
receivable;
-
Variable lease payments that are
based on an index or a rate, initially measured using the index or
rate as at the commencement date;
-
Amounts expected to be payable by
the Group under residual value guarantees;
-
The exercise price of a purchase
option if the Group is reasonably certain to exercise that option;
and
-
Payments of penalties for
terminating the lease, if the lease term reflects the Group
exercising that option.
Lease
payments to be made under reasonably certain extension options are
also included in the measurement of the liability.
The lease
payments are discounted using the interest rate implicit in the
lease. If that rate cannot be readily determined, which is
generally the case for leases in the Company, the lessee's
incremental borrowing rate is used, being the rate that the
individual lessee would have to pay to borrow the funds necessary
to obtain an asset of similar value to the right-of-use asset in a
similar economic environment with similar terms, security and
conditions. In all instances the leases were discounted using the
incremental borrowing rate.
Lease
payments are allocated between principal and finance cost. The
finance cost is charged to profit or loss over the lease period.
Right-of-use assets are measured at cost which comprises the
following:
-
The amount of the initial
measurement of the lease liability;
-
Any lease payments made at or before
the commencement date less any lease incentives
received;
-
Any initial direct costs;
and
-
Restoration costs.
Right-of-use assets are depreciated over the shorter of the
asset's useful life and the lease term on a straight line basis. If
the Company is reasonably certain to exercise a purchase option,
the right-of-use asset is depreciated over the underlying asset's
useful life.
Payments
associated with short-term leases (term less than 12 months) and
all leases of low-value assets (generally less than £5k) are
recognised on a straight-line basis as an expense in profit or
loss.
2.21
Government grants
Grants
from the government are recognised at their fair value where there
is reasonable assurance that the grant will be received and the
group will comply with all attached conditions. Government grants
which are revenue in nature are recognised on a systematic basis
within Other operating income in the Statement Profit and Loss and
Other Comprehensive income over the period in which the group
recognises as expenses the related costs for which the grants are
intended to compensate.
2.22
Investments (company accounting
policy)
Investments in subsidiaries are measured at cost less
impairment. If there is objective evidence of impairment, an
impairment loss is recognised in profit or loss. A reversal of an
impairment loss is recognised immediately in profit or loss to the
extent that it eliminates the impairment loss which has been
recognised for the asset in prior years.
2.23
Critical accounting judgements and key
sources of estimation uncertainty
In the
application of the Group's accounting policies, the Directors are
required to make judgments, estimates and assumptions about the
carrying amounts of assets and liabilities that are not readily
apparent from other sources. The estimates and associated
assumptions are based on historical experience and other factors
that are considered to be relevant. Actual results may differ from
these estimates.
The
estimates and underlying assumptions are reviewed on an ongoing
basis. Revisions to accounting estimates are recognised in the
period in which the estimate is revised if the revision affects
only that period or in the period of the revision and future
periods if the revision affects both current and future
periods.
Critical
judgments and sources of estimation uncertainty that have the most
significant effect on the amounts recognised in the financial
statements are as follows:
Identified intangible
assets
Identified
intangible assets arising on acquisition comprise; brand
intellectual property, customer relationships and customer
contracts.
Their value
is estimated based on revenue and EBIT forecasts over 10 years.
Judgements are required regarding the discount rate and Weighted
Average Cost of Capital (WACC). Rates have been bench marked
against similar companies in the industry.
Carrying value of
goodwill
Impairment
reviews for non-current assets are carried out at each balance
sheet date in accordance with IAS 36 Impairment of assets. An
annual impairment review is undertaken for Goodwill for each
operating subsidiary, which are considered to be a separately
identifiable cash generating units. The impairment reviews are
sensitive to various assumptions, including the expected sales
forecasts, cost assumptions, capital requirements, and discount
rate.
Right of use
assets
Judgement
is required regarding the incremental borrowing rate to apply to
leasehold assets to discount the cash flows to present
value.
Contingent
consideration
Contingent
consideration, resulting from business combinations, is valued at
fair value at the acquisition date as part of the business
combination. The determination of fair value is based on key
assumptions including estimation of the level of sales compared to
the performance target. Judgement is also applied in relation to
the discount rate used for deferred consideration.
Share based
payments
Estimating
fair value for share-based payment transactions requires
determination of the most appropriate valuation model, which is
dependent on the terms and conditions of the grant of share options
and warrants. This estimate also requires determination of the most
appropriate inputs to the valuation model including the expected
life, volatility and dividend yield and making assumptions about
them. The assumptions used for estimating fair value for
share-based payment transactions are disclosed in Note
29.
Impairment of investments and
recoverability of loans to subsidiary
undertakings
Investments
in subsidiary undertakings and the recoverability of receivables
from group undertakings. The impairment reviews are sensitive to
various assumptions, including the expected sales forecasts, cost
assumption and discount rate.
3.
SEGMENT REPORTING
For the
purpose of IFRS 8, the Chief Operating Decision Maker takes the
form of the board of directors. The Directors are of the opinion
that the business of the Group focused on four reportable segments
as follows:
Included in
Administration is the Parent company, which includes activities of
raising finance and seeking new investment opportunities, all based
in the UK, whilst S-Ventures Acquisitions Limited is a holding
company which was incorporated during the period and holds
borrowings used to finance the acquisition of Juvela Limited. and
also included in Administration.
The other
three segments relate to the subsidiary undertakings activities,
which include:
-
Plant based nutrition (undertaken by Pulsin Limited, Ohso
Chocolate Limited * and We Love Purely Limited)
-
Bakery (undertaken by Juvela Limited and Lizza Gmbh *,
subsidiaries acquired in the current period and prior year
respectively)
-
Technical services (undertaken by Market Rocket Limited, a
subsidiary acquired in the prior year)
* entities
now regarded as discontinued operations - refer to note
30
The
segmental information for the period ended 31 December 2023 is
shown as below:
|
Plant Based
Nutrition
|
Bakery
|
Tech.
Services
|
Admin
|
Segment
Totals
|
Consol.
Adj.
|
Disc Ops *
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue
|
7,968
|
8,722
|
3,739
|
30
|
20,459
|
-
|
801
|
19,658
|
Gross
profit
|
1,492
|
6,205
|
1,575
|
30
|
9,302
|
-
|
(56)
|
9,358
|
EBITDA
|
(1,789)
|
2,529
|
68
|
(1,481)
|
(673)
|
(2,019)
|
(2,100)
|
(592)
|
Operating
profit / (loss) after tax
|
(3,027)
|
1,729
|
62
|
(3,275)
|
(4,511)
|
(2,124)
|
(2,191)
|
(4,444)
|
Segment
total assets (net of investments in subsidiaries)
|
3,757
|
8,767
|
774
|
567
|
13,865
|
5,787
|
60
|
19,592
|
Segment
liabilities
|
3,270
|
1,031
|
701
|
10,587
|
15,589
|
-
|
194
|
15,395
|
* excluding
the discontinued operations
The
segmental information for the year ended 30 September 2022 is shown
as below:
|
Plant Based
Nutrition
|
Bakery
|
Tech.
Services
|
Admin
|
Segment
Totals
|
Consol.
Adj.
|
Disc Ops *
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue
|
7,254
|
104
|
439
|
4
|
7,801
|
-
|
173
|
7,628
|
Gross
profit
|
2,061
|
(83)
|
414
|
4
|
2,396
|
138
|
(54)
|
2,588
|
EBITDA
|
(1,307)
|
(184)
|
66
|
(1,305)
|
(2,730)
|
1,058
|
(377)
|
(1,295)
|
Operating
profit / (loss) after tax
|
(2,106)
|
(210)
|
62
|
(1,350)
|
(3,604)
|
148
|
(1,074)
|
(2,382)
|
Segment
total assets (net of investments in subsidiaries)
|
6,227
|
2,709
|
256
|
2,208
|
11,400
|
4,991
|
(181)
|
16,391
|
Segment
liabilities
|
4,763
|
2,783
|
111
|
1,273
|
8,930
|
(2,035)
|
(2,087)
|
6,896
|
4.
REVENUE
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Sale of
product
|
|
19,658
|
|
7,628
|
|
|
19,658
|
|
7,628
|
Within the
sales revenue for both the current and previous period, there was
one customer that accounted for greater than 10% of total revenue.
This ceased to be the case shortly after the balance sheet
date.
5.
OTHER OPERATING INCOME
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Miscellaneous income
|
|
90
|
|
45
|
|
|
90
|
|
45
|
6.
EMPLOYEES AND DIRECTORS
Staff
costs, including directors' remuneration is set out
below:
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Wages and
salaries
|
|
3,680
|
|
2,639
|
Social
security costs
|
|
303
|
|
234
|
Other
pension costs
|
|
137
|
|
35
|
|
|
4,120
|
|
2,908
|
The average
monthly number of employees, including the Directors, during the
year was as follows:
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Average
number of employees
|
|
108
|
|
76
|
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Directors'
remuneration (Please refer to the Remuneration Committee Report for
more details)
|
|
389
|
|
252
|
7.
EXCEPTIONAL ITEMS
During the
prior period the Company entered into a settlement deed which
included a combination of cash and share settlement that was less
than the value of the loan convertible notes resulting in a gain on
settlement of the convertible loans of £645,000 shown in the
consolidated statement of profit and loss statement.
8.
NET FINANCE COSTS
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Finance
income:
|
|
|
|
|
Deposit
account interest
|
|
6
|
|
15
|
Interest
on directors loan account
|
|
-
|
|
1
|
|
|
6
|
|
16
|
Finance
costs:
|
|
|
|
|
Bank loan
interest
|
|
808
|
|
1
|
Other loan
interest
|
|
38
|
|
(20)
|
IFRS 16
lease charges
|
|
153
|
|
108
|
Other
financing costs
|
|
250
|
|
-
|
|
|
1,249
|
|
89
|
|
|
|
|
|
Net finance
costs
|
|
1,243
|
|
73
|
9.
LOSS BEFORE INCOME TAX
The loss
before income tax of £4,045,000 (2022: £3,257,000) is stated after
charging / (crediting):
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Cost of
inventories recognised as expense
|
|
10,653
|
|
5,218
|
Depreciation of tangible fixed assets
|
|
613
|
|
320
|
Depreciation of right of use assets
|
|
293
|
|
275
|
Amortisation of intangible assets
|
|
905
|
|
315
|
Foreign
exchange differences
|
|
(1)
|
|
29
|
10.
AUDITORS'
REMUNERATION
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Fees
payable to the Group's auditor in relation to the audit of
the consolidated financial statements
|
|
45
|
|
132
|
Fees
payable to the Group's auditors for other advisory
services
|
|
-
|
|
-
|
|
|
45
|
|
132
|
11.
TAXATION
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Current
year tax credit / (charge)
|
|
|
|
|
Corporation income tax
|
|
-
|
|
-
|
Deferred
tax movement
|
|
399
|
|
199
|
|
|
399
|
|
199
|
The charge
for the year can be reconciled to the profit /(loss) before tax as
follows:
Loss
before tax
|
(4,045)
|
|
(3,257)
|
Loss
before tax calculated at the UK standard rate of tax of 19% 1 Jan
23 to 31 Mar 23 / 25% 1 Apr 23 - 31 Dec 23 (2022: 19%)
|
(951)
|
|
(619)
|
Tax
effects of:
|
|
|
|
Expenses
not deductible for tax
|
37
|
|
100
|
Research
and development enhanced deductions
|
165
|
|
(60)
|
Gain on
settlement of convertible loan notes
|
-
|
|
(645)
|
Consolidation adjustments not deductible for tax:
|
|
|
|
Goodwill
impairment
|
30
|
|
569
|
Amortisation of intangible assets recognised on business
combination
|
200
|
|
312
|
Depreciation of fixed assets revaluation on business
combination
|
-
|
|
74
|
Revaluation of inventory on business combination
|
-
|
|
(85)
|
Deferred
tax asset not provided for
|
918
|
|
353
|
|
-
|
|
-
|
Deferred
tax assets written back from prior year (note 31)
|
399
|
|
199
|
Total tax charge / (credit)
for the year
|
399
|
|
199
|
The
corporation tax rate changed from 19% to 25% from 1 April
2023.
12.
LOSS OF PARENT
COMPANY
As
permitted by Section 408 of the Companies Act 2006, the income
statement of the parent company is not presented as part of these
financial statements. The parent company's loss for the financial
period was £8,964,000 (2022 - loss of £1,350,000).
13.
EARNINGS PER
SHARE
Basic Loss
Per Share (LPS) is calculated by dividing the earnings attributable
to ordinary shareholders by the weighted average number of ordinary
shares outstanding during the period.
The
weighted average diluted number of shares is stated below, but the
diluted LPS is not included as the loss would make it
anti-dilutive.
15 mths
ended
31 December
2023
|
Earnings
£'000
|
Weighted average number of
shares
|
Per-share amount
pence
|
Basic earnings per
share
|
|
|
|
Loss
attributable to ordinary shareholders
|
(6,597)
|
130,936,824
|
(5.04)
|
Warrants
for shares
|
|
737,800
|
|
Weighted
average diluted number of shares
|
|
131,674,624
|
|
Year ended
30 September
2022
|
Earnings
£'000
|
Weighted average number of
shares
|
Per-share amount
pence
|
Basic earnings per
share
|
|
|
|
Loss
attributable to ordinary shareholders
|
(3,456)
|
118,179,305
|
(2.92)
|
Warrants
for shares
|
|
12,410,271
|
|
Weighted
average diluted number of shares
|
|
130,589,576
|
|
14.
SUBSIDIARIES
The Company
holds shares in the following subsidiaries at the balance sheet
date:
Subsidiary
|
% Holding 31 Dec
23
|
% Holding 30 Sep
22
|
Date of
acquisition
|
Nature of
business
|
We Love
Purely Limited *
|
85.1%
|
85.1%
|
22 Jan
2021
|
Plantain
flavoured crisps
|
Ohso
Chocolate Limited *
|
100%
|
100%
|
16 Feb
2021
|
Probiotic
chocolate
|
Pulsin
Limited
|
100%
|
100%
|
23 Jul
2021
|
Plant based
foods
|
Pulsin
BV
|
100%
|
100%
|
23 Jul
2021
|
Holding
company (holds 100% of Lizza Gmbh)
|
Market
Rocket Limited
|
100%
|
100%
|
8 Apr
2022
|
Marketing
|
ML
Manufacturing Limited
|
100%
|
100%
|
20 Oct
2020
|
Manufacturing
|
Lizza
Gmbh
|
100%
|
100%
|
29 Aug
2022
|
Bakery
|
S-Ventures
Acquisitions Limited
|
100%
|
-
|
14 Dec
2022
|
Bakery
|
All
subsidiaries are incorporated in England & Wales, except for
Pulsin BV (incorporated in The Netherlands) and Lizza Gmbh
(incorporated in Germany).
During the
current period, the winding up process of Lizza GmbH by the German
liquidators continued. However, all Lizza's assets have been fully
impaired in these accounts.
Juvela
Limited is the wholly-owned subsidiary of S-Ventures Acquisitions
Limited
* Step
Acquisitions
During the
prior period the parent company acquired an additional 24.9%
shareholding in Ohso Chocolate Limited and a further 10% in We Love
Purely Limited increasing the shareholding to 100% (Ohso) and 85.1%
(We Love Purely).
15.
PURCHASE PRICE
ALLOCATION
Juvela
Limited
On 14
December 2022, 100% of the share capital of Juvela Limited
(formerly Hero UK Limited) ("Juvela") was acquired for a mixture of
cash, shares and deferred consideration.
Juvela is a
business manufacturing gluten-free and free-from products from its
factory in Pontypool, Wales. They have been manufacturing gluten
free food for people diagnosed with coeliac disease for over 25
years and are the leading brand serving the UK coeliac community
under the brand name Juvela.
The
acquisition was made through a newly formed wholly owned subsidiary
- S-Ventures Acquisitions Limited. The consideration of £8.8
million was satisfied as follows:
-
cash consideration of £6.4 million,
payable on completion. This was funded by loans from Shawbrook Bank
of £5.5m and the balance from the parent company's own resources.
One loan for £3.5m is fully amortising over the 4 year term and the
second loan of £2m is repayable at the end of the 4 year term. The
coupon on these loans is SONIA + 5.95% and 7% respectively.;
and
-
the issue of 5 million Ordinary
Shares, which had a fair value of £0.85 million based on the
closing share price on the day prior to completion;
-
deferred consideration payable in
cash on 1 September 2023 of £1.585 m; and
-
stamp duty payables of £0.044
m.
Following
on from the acquisition, a purchase price allocation exercise was
performed with the allocation of the
purchase price of acquisition of the subsidiary undertaking during
the period was as follows:
|
|
|
Juvela Limited
£'000
|
Total
consideration
|
|
|
|
Cash
|
|
|
6,367
|
Shares
issued at market value
|
|
|
850
|
Deferred
consideration - cash (including interest at 8%)
|
|
|
1,586
|
Other
|
|
|
44
|
Total
consideration
|
|
|
8,847
|
Recognised amounts of assets
and liabilities acquired
|
|
|
|
Cash and
cash equivalents
|
|
|
485
|
Trade and
other receivables
|
|
|
1,463
|
Inventories
|
|
|
355
|
Intangible
assets recognised on business combination
|
|
|
5,517
|
Property,
plant and equipment
|
|
|
858
|
Investments
|
|
|
255
|
Trade and
other payables
|
|
|
(886)
|
Borrowings
|
|
|
(343)
|
Total identifiable net
assets
|
|
|
7,704
|
Minority
%age interest
|
|
|
0%
|
Net assets attributable to
parent company
|
|
|
7,704
|
Goodwill
|
|
|
1,143
|
Total
consideration
|
|
|
8,847
|
During the
year a Purchase Price Allocation (PPA) measurement review was
undertaken to ascertain the fair value of the consideration and net
assets of the subsidiary undertaking acquired.
Juvela
Limited
This
included determining identifiable net assets not previously
recognised. Brand IP of £1,919,000 was calculated based on forecast
revenue and estimated royalty rates. Customer relationships of
£2,498,000 were valued based on revenue and EBIT forecasts and
estimated customer attrition rates. Contract based intangible
assets of £1,100,000 were valued using the income approach based on
forecast attributable revenue and estimated royalty rates. All were
discounted at the weighted average cost of capital.
Deferred
cash consideration of £1,500,000 to be settled by 30 September 2023
attracted an interest rate of 8%.
Shares
issued in the parent company as part of the consideration are based
on the average market value per the AQSE stock exchange on the date
of acquisition.
The
allocation of the purchase price of the subsidiary undertakings
acquired during the prior year was as follows:
|
Market Rocket Limited
£'000
|
|
Lizza Gmbh
£'000
|
Total
consideration
|
|
|
|
Cash
|
100
|
|
-
|
Shares
issued at market value
|
673
|
|
-
|
Deferred
consideration - cash
|
350
|
|
-
|
Contingent
consideration - shares
|
112
|
|
-
|
Total
consideration
|
1,235
|
|
-
|
Recognised amounts of assets
and liabilities acquired
|
|
|
|
Cash and
cash equivalents
|
84
|
|
7
|
Trade and
other receivables
|
46
|
|
146
|
Inventories
|
-
|
|
356
|
Intangible
assets recognised on business combination
|
430
|
|
-
|
Property,
plant and equipment
|
21
|
|
-
|
Tax
liabilities /asset
|
(15)
|
|
-
|
Trade and
other payables
|
(72)
|
|
(114)
|
Borrowings
|
-
|
|
(650)
|
Total identifiable net
assets
|
494
|
|
(255)
|
Minority
%age interest
|
0%
|
|
0%
|
Net assets attributable to
parent company
|
494
|
|
(255)
|
Goodwill
|
741
|
|
255
|
Total
consideration
|
1,235
|
|
-
|
During the
prior year a Purchase Price Allocation (PPA) measurement review was
undertaken to ascertain the fair value of the consideration and net
assets of the subsidiary undertakings acquired.
Market Rocket
Limited
This
included determining identifiable net assets not previously
recognised. Brand IP of £23,000 was calculated based on forecast
revenue and estimated royalty rates. Customer relationships of
£407,000 were valued based on revenue and EBIT forecasts and
estimated customer attrition rates. Both were discounted at the
weighted average cost of capital.
Deferred
and contingent consideration are discounted at the estimated cost
of debt of 9.6%. Contingent consideration is based on future
performance criteria, which was expected to be met at the date of
acquisition.
Shares
issued in the parent company as part of the consideration are based
on the average market value per the AQSE stock exchange on the date
of acquisition.
Lizza Gmbh
As referred
to in note 30, Lizza Gmbh has been put into formal German
insolvency proceedings in April 2023, which was just 7 months after
the date of acquisition. The assets were therefore reviewed for
impairment in determining the fair values at acquisition. The fixed
assets with a carrying value of £683,000 at acquisition were
impaired in full to reflect that they have no value in use due to
recurring losses. A review of stock sales after date resulted in a
stock impairment of £52,000. The goodwill of £255,000 has been
impaired in full.
During the
prior year the purchase price allocation measurement review was
undertaken for subsidiaries acquired in the previous year. The
following purchase price allocation adjustments were made in the
prior year as a result of the review:
|
Pulsin Limited
£'000
|
Ohso Chocolate Limited
£'000
|
We Love Purely Limited
£'000
|
Revaluation of tangible
assets
|
|
|
|
Plant and
machinery
|
741
|
-
|
-
|
|
|
|
|
Identifiable intangible
assets
|
|
|
|
Brand
intellectual property
|
247
|
80
|
82
|
Customer
relationships
|
2,116
|
105
|
61
|
Less:
|
|
|
|
Development cost intangibles derecognised
|
(52)
|
-
|
-
|
Inventory
|
(62)
|
(23)
|
-
|
Increase in identifiable net
assets
|
2,990
|
162
|
143
|
Minority
%age interest
|
0
|
24.90
|
24.90
|
Minority
interest in net assets increase
|
-
|
(40)
|
(36)
|
Increase in net assets
attributable to parent
|
2,990
|
122
|
107
|
|
|
|
|
Reduction
on deferred purchase consideration
|
34
|
-
|
-
|
Reduction in
Goodwill
|
(3,024)
|
(122)
|
(107)
|
The total
reduction in Goodwill as a result of the purchase price allocation
adjustments was £3,253,000.
A
significant adjustment was the revaluation of Plant and Machinery
in Pulsin to fair value, taking into account the estimated market
value at the date of acquisition, resulting in an uplift from book
value of £741,000.
Identifiable net assets not previously recognised were valued
and recognised. This included Brand IP, which was calculated based
on forecast revenue and estimated royalty rates. Customer
relationships were valued based on revenue and EBIT forecasts and
estimated customer attrition rates. Both were discounted at the
weighted average cost of capital.
Stock was
revalued to take account of selling costs. As the stock has been
sold in the prior year, the reduction in stock value was credited
to the profit and loss account.
16.
GOODWILL
Group
|
£'000
|
COST OR
VALUATION
|
|
At 1
October 2021
|
6,658
|
Additions
|
1,062
|
Purchase
price allocation adjustment (note 15)
|
(3,253)
|
Impairments
|
(569)
|
At 30 September
2022
|
3,898
|
Additions
|
-
|
Purchase
price allocation (note 15)
|
1,143
|
Impairments
|
(1,578)
|
At 31 December
2023
|
3,463
|
|
|
NET BOOK
VALUE
|
|
At 30
September 2022
|
3,898
|
At 31 December
2023
|
3,463
|
See note 15
in respect of the reduction in goodwill following the purchase
price allocation (PPA) review in the prior year. An impairment
review was undertaken in the current year, resulting in the write
off of goodwill in full for Lizza Gmbh and Ohso Chocolate
Limited.
17.
INTANGIBLE
ASSETS
Group
|
Brand intellectual
property
£'000
|
Development
costs
£'000
|
Customer Relationships
£'000
|
Contracts
£'000
|
|
Total
£'000
|
Cost
|
|
|
|
|
|
|
At 1
October 2021
|
5
|
53
|
-
|
-
|
|
58
|
Additions
|
180
|
-
|
-
|
-
|
|
180
|
Disposals
|
-
|
(53)
|
-
|
-
|
|
(53)
|
Recognition on subsidiary acquisitions (Purchase price
allocation - note 15)
|
434
|
-
|
2,685
|
-
|
|
3,119
|
At 30
September 2022
|
619
|
-
|
2,685
|
-
|
|
3,304
|
Additions
|
201
|
-
|
-
|
-
|
|
201
|
Disposals
|
-
|
-
|
-
|
-
|
|
-
|
Recognition on subsidiary acquisitions (Purchase price
allocation - note 15)
|
2,980
|
-
|
3,879
|
1,708
|
|
8,567
|
At 31
December 2023
|
3,800
|
-
|
6,564
|
1,708
|
|
12,072
|
|
|
|
|
|
|
|
Amortisation
|
|
|
|
|
|
|
At 1
October 2021
|
-
|
3
|
-
|
-
|
|
3
|
Amortisation for period
|
45
|
-
|
270
|
-
|
|
315
|
Eliminated
on disposal
|
-
|
(3)
|
-
|
-
|
|
(3)
|
At 30
September 2022
|
45
|
-
|
270
|
-
|
|
315
|
Amortisation
|
511
|
-
|
401
|
176
|
|
1,088
|
Disposals
|
-
|
-
|
-
|
-
|
|
-
|
Recognition on subsidiary acquisitions (Purchase price
allocation - note 15)
|
1,061
|
-
|
1,381
|
608
|
|
3,050
|
At 31
December 2023
|
1,617
|
-
|
2,052
|
784
|
|
4,453
|
|
|
|
|
|
|
|
Net book
value
|
|
|
|
|
|
|
At 30
September 2022
|
394
|
-
|
2,415
|
-
|
|
2,989
|
At 31 December
2023
|
2,183
|
-
|
4,512
|
924
|
|
7,619
|
18.
PROPERTY, PLANT AND
EQUIPMENT
Group
|
Leasehold
improve-ments
£'000
|
Plant & machinery
£'000
|
Fixture and fittings
£'000
|
Computer equipment
£'000
|
|
Total
£'000
|
Cost
|
|
|
|
|
|
|
At 1
October 2021
|
76
|
1,025
|
18
|
166
|
|
1,285
|
Additions
|
28
|
255
|
10
|
76
|
|
369
|
Additions
on acquisition of subsidiary undertaking
|
-
|
-
|
20
|
-
|
|
20
|
Disposals
|
-
|
(2)
|
(4)
|
-
|
|
(6)
|
Acquisition revaluation to fair value (note 15)
|
-
|
741
|
-
|
-
|
|
741
|
At 30
September 2022
|
104
|
2,019
|
44
|
242
|
|
2,409
|
Additions
|
7
|
181
|
7
|
51
|
|
246
|
Disposals
|
-
|
(302)
|
(9)
|
(23)
|
|
(334)
|
Transferred to discontinued operations
|
-
|
(61)
|
(4)
|
(9)
|
|
(74)
|
Additions
on acquisition of subsidiary undertaking (note 15)
|
-
|
1,483
|
-
|
285
|
|
1,768
|
At 31
December 2023
|
111
|
3,320
|
38
|
546
|
|
4,015
|
|
|
|
|
|
|
|
Depreciation
|
|
|
|
|
|
|
At 1
October 2021
|
7
|
52
|
1
|
6
|
|
66
|
Charge for
the year
|
33
|
202
|
8
|
77
|
|
320
|
Elimination on disposal
|
-
|
(2)
|
(1)
|
-
|
|
(3)
|
At 30
September 2022
|
40
|
252
|
8
|
83
|
|
383
|
Charge for
the period
|
46
|
567
|
17
|
103
|
|
733
|
Elimination on disposal
|
-
|
(157)
|
(8)
|
(13)
|
|
(178)
|
Transferred to discontinued operations
|
-
|
(24)
|
(4)
|
(9)
|
|
(37)
|
Additions
on acquisition of subsidiary undertaking (note 15)
|
-
|
641
|
-
|
269
|
|
910
|
At 31
December 2023
|
86
|
1,279
|
13
|
433
|
|
1,811
|
|
|
|
|
|
|
|
Net book
value
|
|
|
|
|
|
|
At 30
September 2022
|
64
|
1,767
|
36
|
159
|
|
2,026
|
At 31 December
2023
|
25
|
2,041
|
25
|
113
|
|
2,204
|
Company
|
Computer equipment
£'000
|
|
Total
£'000
|
Cost
|
|
|
|
At 1
October 2021
|
5
|
|
5
|
Additions
|
22
|
|
22
|
At 30
September 2022
|
27
|
|
27
|
Additions
|
-
|
|
-
|
At 31
December 2023
|
27
|
|
27
|
|
|
|
|
Depreciation
|
|
|
|
At 1
October 2021
|
1
|
|
1
|
Charge for
the year
|
4
|
|
4
|
At 30
September 2022
|
5
|
|
5
|
Charge for
the period
|
5
|
|
5
|
At 31
December 2023
|
10
|
|
10
|
|
|
|
|
Net book
value
|
|
|
|
At 30
September 2022
|
22
|
|
22
|
At 31 December
2023
|
17
|
|
17
|
19.
INVESTMENTS
Group
|
Associate
£'000
|
Unlisted Investments
£'000
|
|
Total
£'000
|
Cost
|
|
|
|
|
At 1
October 2021
|
-
|
30
|
|
30
|
Additions
|
-
|
-
|
|
-
|
At 30
September 2022
|
-
|
30
|
|
30
|
Additions
|
-
|
-
|
|
-
|
At 31
December 2023
|
-
|
30
|
|
30
|
|
|
|
|
|
Net book
value
|
|
|
|
|
At 30
September 2022
|
-
|
30
|
|
30
|
At 31 December
2023
|
-
|
30
|
|
30
|
Company
|
Shares in group undertakings
£'000
|
Unlisted Investments
£'000
|
|
Total
£'000
|
Cost
|
|
|
|
|
At 1
October 2021
|
7,394
|
30
|
|
7,424
|
Additions
|
1,284
|
-
|
|
1,284
|
Impairments
|
(305)
|
-
|
|
(305)
|
At 30
September 2022
|
8,373
|
30
|
|
8,403
|
Additions
|
1,500
|
-
|
|
1,500
|
Impairments
|
(6,447)
|
-
|
|
(6,417)
|
At 31
December 2023
|
3,426
|
30
|
|
3,456
|
|
|
|
|
|
Net book
value
|
|
|
|
|
At 30
September 2022
|
8,373
|
30
|
|
8,403
|
At 31 December
2023
|
3,426
|
30
|
|
3,456
|
During the
current year the Company incorporated S-Ventures Acquisitions
Limited for the purpose of acquiring 100% of the following
subsidiary undertaking:
Subsidiary
|
Cost
£'000
|
Acquisition
date
|
Principal
activity
|
Country of
incorporation
|
Juvela
Limited (formerly Hero UK Limited
|
8,847
|
14
December 2022
|
Bakery
|
England
|
Additionally the Company invested a further £1,500,000 into
Pulsin Limited during the current year.
During the
prior year the company acquired 100% of the following subsidiary
undertakings:
Subsidiary
|
Cost
£'000
|
Acquisition
date
|
Principal
activity
|
Country of
incorporation
|
Market
Rocket Limited
|
1,283
|
8 April
2022
|
Marketing
|
England
|
Lizza
GMBH
|
-
|
29 August
2022
|
Bakery
|
Germany
|
An
impairment review was undertaken during the prior year and the
investment cost of £305,000 in Ohso Chocolate Limited has been
impaired to £nil.
20.
INVENTORY
|
|
31 Dec 2023
£'000
|
|
30 Sep 2022
£'000
|
Raw
materials
|
|
680
|
|
471
|
Stocks
|
|
978
|
|
844
|
Packaging
|
|
198
|
|
332
|
|
|
1,856
|
|
1,647
|
21.
TRADE AND OTHER
RECEIVABLES
|
Group
|
|
Company
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Trade
receivables
|
2,445
|
1,589
|
|
53
|
61
|
Amounts
owed by group undertakings
|
-
|
-
|
|
5,621
|
2,632
|
Amounts
owed by associates
|
-
|
178
|
|
-
|
178
|
Other
receivables
|
11
|
77
|
|
-
|
14
|
Directors'
current accounts
|
98
|
-
|
|
-
|
-
|
VAT
|
33
|
62
|
|
-
|
17
|
Prepayments and accrued income
|
295
|
693
|
|
9
|
162
|
|
2,882
|
2,599
|
|
5,683
|
3,064
|
Amounts
owed to group undertakings are net of expected credit losses of
£541,000 (2022: £680,000). Other receivables are net of expected
credit losses of £20,000, (2022: £20,000). Trade receivables do not
include any material past due debts and based on historic
recoverability no impairment is required in respect of expected
credit losses.
22.
CASH AND CASH
EQUIVALENTS
|
Group
|
|
Company
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Bank
accounts
|
305
|
1,782
|
|
22
|
1,723
|
|
305
|
1,782
|
|
22
|
1,723
|
23.
CALLED UP SHARE
CAPITAL
|
|
31 Dec
2023
|
|
30 Sep
2022
|
Ordinary
Shares
|
|
|
|
|
Issued and
fully allotted with a nominal value of 0.01p (2022:
0.01p)
|
|
|
|
|
Number of
shares
|
|
132,215,587
|
|
125,571,687
|
Nominal
value (£'000)
|
|
132
|
|
126
|
Share
premium (£'000)
|
|
14,708
|
|
13,509
|
|
|
No.
|
Nominal Value
£'000
|
Share Premium
£'000
|
Balance at
1 October 2021
|
|
111,377,947
|
111
|
6,490
|
Shares
issued for cash
|
|
7,142,856
|
7
|
4,993
|
Shares
issued in connection of acquisitions
|
|
5,107,142
|
5
|
1,905
|
Shares
issued on the exercise of warrants
|
|
1,250,000
|
1
|
24
|
Shares
issued for services
|
|
156,250
|
1
|
50
|
Shares
issued on the exercise of options
|
|
537,492
|
1
|
47
|
Total
issued during the year
|
|
14,193,740
|
15
|
7,019
|
Balance at
30 September 2022
|
|
125,571,687
|
126
|
13,509
|
Shares
issued in connection of acquisitions
|
|
5,000,000
|
5
|
845
|
Shares
issued on the exercise of warrants
|
|
1,643,900
|
1
|
354
|
Total
issued during the year
|
|
6,643,900
|
6
|
1,199
|
Balance at
31 December 2023
|
|
132,215,587
|
132
|
14,708
|
Issue Date
|
|
Price per share
£
|
Number
|
Consider-ation
£'000
|
NominalValue
£'000
|
Share Premium
£'000
|
14 Dec
22
|
Juvela
Limited acquisition
|
0.170
|
5,000,000
|
850
|
5
|
845
|
30 Jan
23
|
Warrants
exercised
|
0.250
|
1,400,000
|
350
|
1
|
349
|
9 Feb
23
|
Warrants
exercised
|
0.020
|
237,800
|
4
|
-
|
4
|
9 Feb
23
|
Warrants
exercised
|
0.040
|
6,100
|
1
|
-
|
1
|
Issued in period ended 31 Dec
2023
|
|
6,643,900
|
1,205
|
6
|
1,199
|
Issue Date
|
|
Price per share
£
|
Number
|
Consider-ation
£'000
|
NominalValue
£'000
|
Share Premium
£'000
|
Oct-Dec
21
|
Warrants
exercised
|
0.020
|
1,000,000
|
20
|
1
|
19
|
1 Nov
21
|
Consultancy services
|
0.320
|
156,250
|
50
|
-
|
50
|
1 Dec
21
|
Cash share
issue
|
0.700
|
4,285,714
|
3,000
|
4
|
2,996
|
11 Feb
22
|
Warrants
exercised
|
0.020
|
250,000
|
5
|
-
|
5
|
17 Feb
22
|
For trade
and asset purchase
|
0.700
|
321,429
|
225
|
1
|
224
|
1 Mar
22
|
Share
options exercised
|
0.090
|
268,746
|
24
|
-
|
24
|
11 Apr
22
|
Market
Rocket Ltd acquisition
|
0.314
|
2,142,857
|
673
|
2
|
671
|
13 Jun
22
|
Convertible loan note settlement
|
0.383
|
2,642,856
|
1,012
|
3
|
1,009
|
13 Aug
22
|
Cash share
issue
|
0.700
|
2,857,142
|
2,000
|
3
|
1,997
|
30 Sep
22
|
Share
options exercised
|
0.090
|
268,746
|
24
|
-
|
24
|
Issued in year ended 30 Sep
2022
|
|
14,193,740
|
7,033
|
14
|
7,019
|
Warrants
The
warrants in existence for the issue of new Ordinary Shares of
£0.001 each can be summarised as:
|
Issued for investment
services
Exercise Price £0.02
each
|
Issued for investment
services
Exercise Price £0.04
each
|
Issued with shares as part of
fund raise
|
Latest date for
exercise
|
Exercise
price
|
|
Number
|
Number
|
Number
|
|
£
|
B/f as at 1
Oct 2021
|
1,487,800
|
743,900
|
-
|
1 Sep
2025
|
|
B/f as at 1
Oct 2022
|
-
|
-
|
10,000,000
|
30 Apr
2023
|
0.25
|
Allotted
in Dec 2021 raise
|
|
|
1,428,571
|
20 Dec
2023
|
2.00
|
Exercised
in the period
|
(1,250,000)
|
-
|
-
|
|
|
Balance at
30 Sept 2022
|
237,800
|
743,900
|
11,428,571
|
|
|
Exercised
in the period
|
(237,800)
|
(6,100)
|
|
|
|
Exercised
in the period
|
-
|
-
|
(1,400,000)
|
|
0.25
|
Lapsed
during the period
|
-
|
-
|
(8,600,000)
|
|
0.25
|
Lapsed
during the period
|
-
|
-
|
(1,428,571)
|
|
2.00
|
Balance at
31 Dec 2023
|
-
|
737,800
|
-
|
|
|
The
warrants exercised during the period realised a total of £355,000
(2022: £25,000) cash to the Company.
24.
RESERVES
The
movement in reserves is set out in the Statement of changes in
equity. The group has the following reserves in addition to the
retained deficit reserve:
Share based payment
reserve
The
share-based payment reserve arose from the share-based payment
charge for share options issued to group employees. The shares over
which the options were issued are that of the parent company. It
also includes share warrants issued to a supplier of the parent for
services provided. Details of share-based transactions are included
in note 32.
Contingent equity settled
consideration reserve
The
contingent consideration reserve is the estimated fair value of the
consideration payable to a subsidiary, subject to performance
targets, to be settled by the issue of shares in the parent
company. During the year two subsidiaries were acquired with
contingent equity settled consideration totalling £112,131. The
contingent equity settled consideration recognised in the prior
year of £34,484 was not payable as part of a settlement deed with
the sellers.
Equity component of
convertible debt reserve
This
represents the equity component of convertible loans. The parent
had the option to convert the loan principal into shares at its
discretion. Originally the loan notes were negotiated without a
conversion option at the same coupon rates, so the interest rates
would be the same without the conversion option. Therefore, no
discounting was required and the full principal has been classified
as equity. The loan note interest was included in accruals. During
the year the company agreed a settlement deed for the company's
loans, which involved settlement by shares and cash as set out in
the statement of changes in equity. There was a gain in settlement
of £645,064.
25.
TRADE AND OTHER
PAYABLES
|
Group
|
|
Company
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Deferred
consideration for acquisition
|
1,091
|
366
|
|
1,091
|
366
|
Trade
payables
|
2,240
|
1,913
|
|
680
|
437
|
Amounts
owing to group undertakings
|
-
|
-
|
|
387
|
-
|
Social
security and other taxes
|
853
|
233
|
|
1
|
48
|
Other
payables
|
325
|
61
|
|
99
|
26
|
Accruals
and deferred income
|
756
|
517
|
|
265
|
224
|
Directors'
loan
|
63
|
172
|
|
13
|
172
|
|
5,328
|
3,262
|
|
2,536
|
1,273
|
26.
BORROWINGS
|
|
Group
|
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Current:
|
|
|
|
Bank
overdrafts
|
|
-
|
276
|
Bank
loans
|
|
1,180
|
277
|
Other
loans
|
|
402
|
445
|
|
|
1,582
|
998
|
Non-current:
|
|
|
|
Bank
loans
|
|
5,910
|
192
|
Other
loans
|
|
459
|
-
|
|
|
6,369
|
192
|
|
|
|
|
|
|
7,951
|
1,190
|
Debt
repayment schedule
Issue Date
|
1 year or less
£'000
|
1-2 years
£'000
|
2-5 years
£'000
|
More than 5 years
£'000
|
|
Total £'000
|
Bank
overdrafts
|
-
|
-
|
-
|
-
|
|
-
|
Bank
loans
|
1,180
|
1,314
|
4,596
|
-
|
|
7,090
|
Other
loans
|
402
|
459
|
-
|
-
|
|
861
|
|
1,582
|
1,773
|
4,596
|
|
|
7,951
|
Issue Date
|
Carrying value
at 31 Dec 23 £'000
|
Maturity
dates
|
Interest
rates
|
Government
backed bounce back loans
|
8
|
Aug 2026
to Apr 2027
|
2.5%
|
Shawbrook
bank loans
|
5,500
|
Dec
2026
|
5.95-7.0%
|
Other bank
loans
|
1,582
|
Dec
24-29
|
varying
|
|
7,090
|
|
|
All loans
are repayable by instalments over the loan term.
27.
FINANCIAL INSTRUMENTS AND
RISK MANAGEMENT
Capital Risk
Management
The Company
manages its capital to ensure that entities in the Group will be
able to continue as a going concern while maximising the return to
stakeholders. The overall strategy of the Company and the Group is
to minimise costs and liquidity risk.
The capital
structure of the Group consists of equity attributable to equity
holders of the parent, comprising issued share capital, foreign
exchange reserves and retained earnings as disclosed in the
Consolidated Statement of Changes of Equity.
The Group
is exposed to a number of risks through its normal operations, the
most significant of which are interest, credit, foreign exchange,
and liquidity risks. The management of these risks is vested to the
Board of Directors.
Credit Risk
Credit risk
arises on financial instruments such as trade receivables,
short-term bank deposits.
Policies
and procedures exist to ensure that customers have an appropriate
credit history.
Counterparty exposure positions are monitored regularly so
that credit exposures to any one counterparty are within acceptable
limits.
At the
balance sheet date there were no significant concentrations of
credit risk.
Trade and
other receivables and contract assets included in the balance sheet
are stated net of expected credit loss (ECL) provisions which have
been estimated on a customer-by-customer basis, based on the
relationship with the customer and its historical payment profile.
There are no provisions held against trade receivables at the
balance sheet date.
The Group's
maximum exposure to credit by class of individual financial
instrument is shown in the table below:
|
2023
Carrying
Value
|
2023
Maximum
Exposure
|
2022
Carrying
Value
|
2023
Maximum
Exposure
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Cash and
cash equivalents
|
305
|
305
|
1,782
|
1,782
|
Trade
receivables
|
2,716
|
2,716
|
1,589
|
1,589
|
|
3,021
|
3,021
|
3,371
|
3,371
|
|
|
|
|
|
Interest rate
risk
Loans are
at a fixed rate of interest so the company is not exposed to an
increase in interest rates.
Currency
risk
A
subsidiary has costs arising in US dollars. The group does not
hedge its foreign exposure currently but this kept under review and
as the sales of the subsidiary grow it will look into locking
exchange rates. At 31 December 2023 and 30 September 2022 the Group
did not have a material foreign currency exposure.
Liquidity
risk
Working
capital is carefully managed to minimise liquidity risk. Management
continually monitor the Group's actual and forecast cash flows and
cash positions. Where issues arise, we work with the Supplier to
ensure continued supply in some cases rescheduling the payment
terms. The CEO has provided a line of credit of £0.5m to support
the business as required at an interest rate of 15% with no fixed
repayment term.
28.
FINANCIAL ASSETS AND FINANCIAL LIABILITIES
Group
2023
|
|
|
Financial assets at amortised
cost
|
Financial liabilities at
amortised cost
|
Total
|
Financial assets /
liabilities
|
|
|
£'000
|
£'000
|
£'000
|
Trade and
other receivables 1
|
|
|
2,858
|
-
|
2,858
|
Cash and
cash equivalents
|
|
|
305
|
-
|
305
|
Trade and
other payables 2
|
|
|
-
|
(4,572)
|
(4,572
|
Lease
liabilities (current and non-current)
|
|
|
-
|
(1,676)
|
(1,676)
|
|
|
|
3,163
|
(6,248)
|
(3,085)
|
1 Trade and other receivables
excludes prepayments.
2 Trade and other payables
excludes accruals.
Group
2022
|
|
|
Financial assets at amortised
cost
|
Financial liabilities at
amortised cost
|
Total
|
Financial assets /
liabilities
|
|
|
£'000
|
£'000
|
£'000
|
Trade and
other receivables 1
|
|
|
1,906
|
-
|
1,906
|
Cash and
cash equivalents
|
|
|
1,782
|
-
|
1,782
|
Trade and
other payables 2
|
|
|
-
|
(2,745)
|
(2,745)
|
Lease
liabilities (current and non-current)
|
|
|
-
|
(2,121)
|
(2,121)
|
|
|
|
3,688
|
(4,866)
|
(1,178)
|
1 Trade and other receivables
excludes prepayments.
2 Trade and other payables
excludes accruals.
Company
2023
|
|
|
Financial assets at amortised
cost
|
Financial liabilities at
amortised cost
|
Total
|
Financial assets /
liabilities
|
|
|
£'000
|
£'000
|
£'000
|
Trade and
other receivables 1
|
|
|
5,720
|
-
|
5,720
|
Cash and
cash equivalents
|
|
|
22
|
-
|
22
|
Trade and
other payables 2
|
|
|
-
|
(2,271)
|
(2,271)
|
|
|
|
5,742
|
(2,271)
|
3,471
|
1 Trade and other receivables
excludes prepayments.
2 Trade and other payables
excludes accruals.
Company
2022
|
|
|
Financial assets at amortised
cost
|
Financial liabilities at
amortised cost
|
Total
|
|
Financial assets /
liabilities
|
|
|
£'000
|
£'000
|
£'000
|
|
Trade and
other receivables 1
|
|
|
2,902
|
-
|
2,902
|
|
Cash and
cash equivalents
|
|
|
1,723
|
-
|
1,723
|
|
Trade and
other payables 2
|
|
|
-
|
(1,049)
|
(1,049)
|
|
|
|
|
4,625
|
(1,049)
|
3,576
|
|
1 Trade and other receivables
excludes prepayments.
2 Trade and other payables
excludes accruals.
29.
LEASES
The Group
had the following lease assets and liabilities:
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Right-of-use
assets
|
|
|
|
Property
plant and equipment
|
|
1,233
|
1,419
|
|
|
1,233
|
1,419
|
Lease
liabilities
|
|
|
|
Current
|
|
1,340
|
434
|
Non-current
|
|
336
|
1,686
|
|
|
1,676
|
2,120
|
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Maturity on the lease
liabilities are as follows:
|
|
|
|
Current
|
|
1,340
|
434
|
Due
between 1-5 years
|
|
336
|
1,122
|
Due beyond
5 years
|
|
-
|
564
|
|
|
1,676
|
2,120
|
Right of use
assets
A
reconciliation of the carrying amount of the right-of-use asset is
as follows:
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Opening
balance
|
|
1,419
|
1,694
|
Additions
|
|
255
|
-
|
Depreciation
|
|
(441)
|
(275)
|
|
|
1,233
|
1,419
|
Lease
liabilities
A
reconciliation of the carrying amount of the lease liabilities is
as follows:
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
Opening
balance
|
|
2,121
|
2,430
|
Additions
|
|
255
|
-
|
Payment
made
|
|
(853)
|
(417)
|
Finance
charge
|
|
153
|
108
|
|
|
1,676
|
2,121
|
30.
DISCONTINUED
OPERATIONS
During the
year, the Board reviewed the commercial viability of a number of
the Group's operating subsidiaries and determined that a number of
its subsidiary operations forecast negative cashflows as a result
of falling sales and rising costs. As a result, the following
subsidiaries have been classified as discontinued
operations:
-
Lizza GmBH;
-
Osho Chocolates Limited; and
-
ML Manufacturing Limited.
In
accordance with IFRS 5, the results of these discontinued
operations are presented as follows:
|
|
15 mths ended
31 December 2023
£'000
|
|
Year ended 30 September
2022
£'000
|
Continuing
operations
|
|
|
|
|
Revenue
|
|
801
|
|
315
|
Cost of
sales
|
|
(857)
|
|
(364)
|
Gross profit /
(loss)
|
|
(56)
|
|
(49)
|
Gain /
(loss) on disposal / administration
|
|
(942)
|
|
-
|
Operating
expenses
|
|
(1,102)
|
|
(327)
|
Earnings before interest,
taxation, depreciation and amortisation
|
|
(2,100)
|
|
(376)
|
Depreciation, amortisation and impairment
|
|
(86)
|
|
(645)
|
Finance
costs - net
|
|
(5)
|
|
(6)
|
Loss before
taxation
|
|
(2,191)
|
|
(1,027)
|
Income
tax
|
|
-
|
|
(47)
|
Loss for the
period
|
|
(2,191)
|
|
(1,074)
|
Assets and Liabilities of
Discontinued Operations
|
|
As at 31 December
2023
£
|
|
As at 30 September
2022
£
|
NON-CURRENT
ASSETS
|
|
|
|
|
Intangible
assets
|
|
-
|
|
144
|
Property,
plant and equipment
|
|
-
|
|
37
|
|
|
-
|
|
181
|
CURRENT
ASSETS
|
|
|
|
|
Trade and
other receivables
|
|
53
|
|
229
|
Inventory
|
|
3
|
|
395
|
Cash and
cash equivalents
|
|
4
|
|
17
|
|
|
60
|
|
641
|
|
|
|
|
|
TOTAL
ASSETS
|
|
60
|
|
822
|
|
|
|
|
|
NON-CURRENT
LIABILITIES
|
|
|
|
|
Borrowings
|
|
-
|
|
33
|
|
|
-
|
|
33
|
CURRENT
LIABILITIES
|
|
|
|
|
Borrowings
|
|
77
|
|
712
|
Trade and
other payables
|
|
117
|
|
2,164
|
|
|
194
|
|
2,876
|
TOTAL
LIABILITIES
|
|
194
|
|
2,909
|
|
|
|
|
|
NET ASSETS OF DISCONTINUED
OPERATIONS
|
|
(134)
|
|
(2,087)
|
31.
DEFERRED
TAX
Due to
uncertainty regarding the timing of future taxable profits to
utilise the losses carried forward, the deferred tax assets
recognised in the prior year, comprised of losses carried forward
less accelerated capital allowances, have been written off to the
profit and loss account in the current year.
The total
group deferred tax asset written off is £399,000 (2022:
£199,000).
The total
parent company deferred tax asset written off is £nil (2022:
£56,000).
32.
DIRECTORS' ADVANCES, CREDITS
AND GUARANTEES
The
following advances and credits to a director subsisted during the
period ended 31 December 2023 and the year ended 30 September
2022:
|
|
31 Dec 2023
£'000
|
30 Sep 2022
£'000
|
S P
Livingston:
|
|
|
|
Balance
owed (from) / to the company at the start of the period
|
|
(171)
|
45
|
Amounts
advanced
|
|
502
|
4
|
Amounts
repaid
|
|
(733)
|
(49)
|
Loans from
the director to the company
|
|
(459)
|
(171)
|
Balance
owed (from) / to the company at the end of the period
|
|
(861)
|
(171)
|
Loans to
directors are subject to Interest at the HMRC beneficial loan rate
of 2.25% and are repayable on demand. During the prior year, the
director repaid the previous year balance owed to the company in
full and provided loans totalling £171,000 to the company. At the
balance sheet date, the company owed the director £861,000. Loans
from the director to the company are interest free and repayable on
demand.
33.
RELATED PARTY
DISCLOSURES
Transactions between the Company and its subsidiaries, which
are related parties, have been eliminated on
consolidation.
Loans from
the directors during the period are disclosed within the Advances,
credits and guarantee note 32.
34.
SHARE BASED PAYMENT
TRANSACTIONS
Movements
in the number of share based payment options and warrants and their
weighted average exercise prices are as follows:
|
Number of share based payment
options
|
Weighted average exercise
price of options
|
|
Number of share based payment
warrants *
|
Weighted average exercise
price of warrants
|
Balance
bought forward
|
2,407,928
|
|
|
2,231,700
|
|
Lapsed
during the period
|
(1,870,436)
|
|
|
-
|
|
Exercised
during the period
|
(537,492)
|
|
|
(1,250,000)
|
£0.02
|
Balance at
30 Sep 2022
|
-
|
-
|
|
981,700
|
£0.04
|
Exercised
during the period
|
|
|
|
(237,800)
|
£0.02
|
Exercised
during the period
|
|
|
|
(6,100)
|
£0.04
|
Balance at
31 Dec 2023
|
|
|
|
737,800
|
£0.0205
|
* The
number of warrants relates to warrants issued as part of share
based payments. Warrants were also issued as part of a share fund
raise. See note 22 for the total number of warrants in
issue.
The
weighted average remaining contractual life of the options is 10
years.
On 16 June
2021, the Company granted 2,407,928 share options to employees with
an exercise price of 9 pence each under an Enterprise Management
Incentive Scheme the Options were exercisable subject to certain
performance conditions being met.
The
performance conditions are based on achievement of sales targets in
specific subsidiary undertakings.
Of the
share options issued only 1,628,386 are expected to vest based on
performance conditions. At the date of grant, these options were
valued using the Black-Scholes option pricing model. The fair value
per options granted and the assumptions used in the calculations
were as follows:
Expected
annual volatility
|
10%
|
Time to
maturity (years)
|
10
years
|
Risk free
interest rate
|
1%
|
Fair value
per option
|
£0.016
|
During the
prior year 537,492 options were exercised and the remaining options
have lapsed due to employees performance conditions not being met
during the current year.
On 1
September 2020 1,487,800 warrants with an exercise price of 2 pence
each and 743,900 with an exercise price of 4 pence each were issued
in lieu of professional fees. The professional fees have been
estimated at £25,000, resulting in a fair value per warrant of
£0.011. During the prior year 1,250,000 of shares were exercised at
a price of 2 pence per share, leaving 237,800 to exercise at 2
pence per share and 743,900 at 4 pence per share.
During the
current period 237,800 2 pence warrants and 6,100 4 pence warrants
were exercised, leaving 737,800 to exercise at 4 pence per
share.
During the
prior year the company entered into a contract with the sister of
the director S Livingston, to provide consultancy fees of £50,000
(to be settled by the issue of shares on commencement.
35.
CAPITAL
COMMITMENTS
There were
no capital commitments at 31 December 2023 and 30 September
2022.
36.
CONTINGENT
LIABILITIES
There were
no contingent liabilities at 31 December 2023 and 30 September
2022.
37.
EVENTS SUBSEQUENT TO PERIOD
END
Proposed Transaction with
Riverfort Global Opportunities plc ("RGO")
In addition
to the £1 million of facilities raised from a Middle Eastern family
office in November 2023, on 28 March 2024, the company raised a
further £2 million of debt facilities from RGO to bridge the
potential purchase of assets and novation of liabilities by RGO
announced to the market on 22 March 2024. The company
continues to progress this important potential transaction with the
final phase of preparation now underway with the issuance of these
audited accounts. The transaction that is proposed is
intended to raise enough capital to settle all of the parent
company's loans, leaving only the subsidiary loan at Juvela in
place and approximately halving the financial debt carried by the
group. RGO have undertaken significant due diligence and the
company anticipates being able to make a further statement shortly
after the publication of these accounts.
Suspension of
Shares
On 1 July
2024, the AQSE share quote was suspended pending submission of
these audited accounts, the preparation of which had been delayed.
The quote will be restored once the accounts are filed.
38.
ULTIMATE CONTROLLING
PARTY
In the
opinion of the directors there is no ultimate controlling
party.